<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>High resolution computed tomography of the lungs</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">High resolution computed tomography of the lungs</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">High resolution computed tomography of the lungs</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Stark, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The initial imaging tool for the lung parenchyma remains the chest radiograph. It is unsurpassed in the amount of information it yields in relation to its cost, radiation dose, availability, and ease of performance. However, the chest radiograph has its limitations. It is normal in 10 to 15 percent of symptomatic patients with proven infiltrative lung disease, in up to 30 percent of those with bronchiectasis, and in close to 60 percent of patients with emphysema [<a href="#rid1">1</a>]. In several studies, the chest radiograph has been shown to have an overall sensitivity of 80 percent and a specificity of 82 percent for detection of diffuse lung disease [<a href="#rid2">2</a>]. Chest radiography could provide a confident diagnosis in only 23 percent of cases, and those confident diagnoses proved correct only in 77 percent of cases.</p><p>For these reasons, high resolution computed tomography (HRCT, also called thin-section CT scanning), is frequently used to help clarify specific problems. Typical features of the lung parenchyma and of the small airways correlate with obstructive or restrictive pulmonary function tests [<a href="#rid3">3</a>].The clinical applications of HRCT will be reviewed here. The principles of CT imaging are discussed separately. (See  <a class="medical medical_review" href="/d/html/6982.html" rel="external">"Principles of computed tomography of the chest"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL APPLICATION OF HRCT</span><span class="headingEndMark"> — </span>HRCT, which has a sensitivity of 95 percent and a specificity approaching 100 percent [<a href="#rid2">2,4-7</a>], can often provide more information than either chest radiography or conventional CT scanning. A confident diagnosis is possible in roughly one-half of cases, and these are proven correct an estimated 93 percent of the time.</p><p>HRCT may be particularly useful in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>It can detect lung disease in symptomatic patients with a normal chest radiograph.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It can provide an accurate assessment of the pattern, distribution, and to a lesser degree, assess the activity and potential reversibility of diffuse lung disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It demonstrates a high correlation between radiographic and histopathologic appearances.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with nondiagnostic findings on chest radiography, it can provide a more specific diagnosis or exclude certain diseases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It can be used to determine the type and site of lung biopsy. (See  <a class="medical medical_review" href="/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It can be used to detect or evaluate specific problems or diagnoses, such as metastatic lesions, solitary pulmonary nodules, emphysema, bullous lung disease, bronchiectasis, and diffuse parenchymal disease.</p><p></p><p>Conventional helical CT scanning is the preferred method for the detection and evaluation of mediastinal disease, rather than HRCT (see  <a class="medical medical_review" href="/d/html/6967.html" rel="external">"Approach to the adult patient with a mediastinal mass"</a>). Multislice, multidetector-row CT scanning employs routinely thin sections of 1 to 1.25 mm and high spatial frequency algorithm which provides "high resolution" in the vast majority of thoracic CT scans. HRCT should be performed without intravenous contrast material injection in order to avoid pseudo-ground-glass opacities or so-called hurricane artifacts.</p><p class="headingAnchor" id="H3"><span class="h2">Resolution</span><span class="headingEndMark"> — </span>The technical features of HRCT include a thin collimation of 1 to 1.25 mm and the use of a high spatial frequency (bone) algorithm. The in–plane spatial resolution of modern CT scanners can reach 0.25 mm. Thus, interlobar fissures, which are 0.15 mm in thickness, can frequently be imaged  (<a class="graphic graphic_diagnosticimage graphicRef82418" href="/d/graphic/82418.html" rel="external">image 1</a>). The pattern of scanning varies with the suspected diagnosis. Scanning should occur at 1 cm intervals for diffuse lung disease but should be limited to the involved area for focal lung processes and solitary pulmonary nodules. In posterobasal lung disease, prone scanning can eliminate gravitational changes or dependent atelectasis that can mimic lung disease  (<a class="graphic graphic_diagnosticimage graphicRef66709" href="/d/graphic/66709.html" rel="external">image 2</a>). Prone scans are useful in patients with subtle abnormalities or with normal chest radiographs. With current multislice, multidetector row helical CT scanners, a complete volumetric, helical data set without gaps is commonly obtained with 1 to 1.25 mm reconstructed section thickness.</p><p class="headingAnchor" id="H30085875"><span class="h2">Normal anatomy</span><span class="headingEndMark"> — </span>The basic lung unit that is regularly visible on HRCT is the secondary pulmonary lobule, which is surrounded by interlobular septa. The diameter of the secondary pulmonary lobule varies from 1 to 2.5 cm. It is formed by a congregation of three to five acini and has a polyhedral shape. It contains core structures formed by pulmonary arteriole, bronchiole and peribronchiolar lymphatics, adjacent lung parenchyma, and septal structures which can contain lymphatic structures as well. An acinus encompasses the lung unit distal to a terminal bronchiole and contains an average of 400 alveoli. It has a diameter of 5 to 10 mm and can occasionally be seen on thin sections. Centrilobular arterial branches are important for localization of pathological processes and are located 5 to 10 mm from the pleura.</p><p class="headingAnchor" id="H4"><span class="h1">HRCT PATTERNS</span><span class="headingEndMark"> — </span>The diagnostic approach for HRCT relies upon the predominant pattern of abnormalities, on the zonal distribution of disease, on associated findings such as pleural plaques, calcifications, thickening, effusions, lymph node enlargement, and the clinical history. Criteria of importance include the chronicity of the disease process and the patient's immune status.</p><p>The basic HRCT patterns are a reflection of altered normal anatomy, including terminal and respiratory bronchioles, alveolar ducts, alveolar sacs, pulmonary arterioles, lymphatics, and the loose interstitial connective tissue network. The patterns include reticular and nodular structures, increased opacity (ground-glass and air space filling or consolidation), and decreased opacity, including cystic lesions, mosaic attenuation, and gas trapping. Accompanying lesions include linear opacities, parenchymal bands and architectural distortion.</p><p class="headingAnchor" id="H5"><span class="h2">Reticular pattern</span><span class="headingEndMark"> — </span>The interstitial pulmonary network is responsible for the reticular pattern. It is composed of the axial (ie, bronchovascular) interstitium, the interlobular (including subpleural and sub-fissural) interstitium, and the alveolar-septal (ie, intralobular) interstitium. The pulmonary lymphatics follow the interstitial network.</p><p>A reticular pattern can be classified as large (coarse), intermediate, or fine. The large (coarse) reticular pattern (1 cm) is due to thickening of interlobular septa; intermediate reticular changes can be seen with honeycombing, which form stacked subpleural, small cystic spaces; fine reticular changes are seen with alveolar-septal, intralobular thickening. Irregular intersecting lines can produce a "steel wool" pattern.</p><p class="headingAnchor" id="H30085887"><span class="h2">Perilobular pattern</span><span class="headingEndMark"> — </span>The perilobular region includes the bordering structures of the secondary pulmonary lobules like pleura, interlobular septa, pulmonary veins, paraseptal interstitium, paraseptal alveoli, and subpleural interstitium. Thickening of these structures can produce a coarse reticular pattern with polygonal and arcade-like opacities. The pattern has been described in up to half of patients with organizing pneumonia [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Nodular pattern</span><span class="headingEndMark"> — </span>Nodular patterns include airspace lesions with fuzzy borders, and interstitial nodules with sharp, unsharp, or stellate margination.</p><p>Sharp interstitial nodules can be seen with [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Langerhans cell histiocytosis (LCH)</p><p class="bulletIndent1"><span class="glyph">●</span>Silicosis</p><p class="bulletIndent1"><span class="glyph">●</span>Metastatic disease</p><p class="bulletIndent1"><span class="glyph">●</span>Miliary tuberculosis</p><p class="bulletIndent1"><span class="glyph">●</span>Disseminated fungal disease</p><p></p><p>Unsharp interstitial nodules are found in [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis</p><p class="bulletIndent1"><span class="glyph">●</span>Subacute phase of hypersensitivity pneumonia</p><p></p><p>Stellate interstitial nodules have been described in [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>LCH (so-called starfish nodules)</p><p></p><p>Nodules can be further classified according to their distribution as:</p><p class="bulletIndent1"><span class="glyph">●</span>Perilymphatic</p><p class="bulletIndent1"><span class="glyph">●</span>Random, hematogenous (capillary pattern), or perivascular</p><p class="bulletIndent1"><span class="glyph">●</span>Centrilobular</p><p class="bulletIndent1"><span class="glyph">●</span>Airspace</p><p></p><p class="headingAnchor" id="H7"><span class="h3">Perilymphatic nodules</span><span class="headingEndMark"> — </span>Perilymphatic nodules are subpleural in location, and are also found along interlobular septa, interlobar fissures, and along bronchovascular bundles. These nodules tend to be nonuniform and patchy in distribution, and have a tendency to cluster. They are most frequently found in sarcoidosis, lymphangitic carcinomatosis, and silicosis. When the clustering occurs in a subpleural location, pseudo-plaques can form. Perilymphatic nodules can be seen with sarcoid-like reactions in the lungs after cancer therapy with check point inhibitors like <a class="drug drug_general" data-topicid="96957" href="/d/drug information/96957.html" rel="external">pembrolizumab</a>.</p><p class="headingAnchor" id="H8"><span class="h3">Random, hematogenous, or perivascular nodules (capillary pattern)</span><span class="headingEndMark"> — </span>Random or perivascular nodules have a similar subpleural distribution but show a uniform and diffuse distribution. They do not cluster. They are the result of hematogenous dissemination and are characteristically found in miliary tuberculosis, miliary fungal disease, septic embolization, and metastatic spread of tumor  (<a class="graphic graphic_diagnosticimage graphicRef75183 graphicRef53000" href="/d/graphic/75183.html" rel="external">image 3A-B</a>). They may have a basal predominance with centrilobular and subpleural location, as well as proximity to their feeding vessels. If small hematogenous metastatic nodules cavitate they can form a so-called "cheerio" pattern. This pattern has also been described in minute pulmonary meningothelial-like nodules, likely related to chemodectomas [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H9"><span class="h3">Centrilobular nodules</span><span class="headingEndMark"> — </span>Centrilobular nodules spare the subpleural region and the lung underlying the interlobar fissures; they are found 5 to 10 mm removed from the pleural surfaces. They have a diffuse or patchy distribution, and tend to surround small vessels. They are found in hypersensitivity pneumonitis, sarcoidosis, LCH, and respiratory, follicular, and cellular bronchiolitis  (<a class="graphic graphic_diagnosticimage graphicRef75540" href="/d/graphic/75540.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef122353" href="/d/graphic/122353.html" rel="external">image 5</a>). Centrilobular nodules are described in rare cases of diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH). Centrilobular nodules with subtle cavitation can be identified in LCH and are another source of a "cheerio" pattern.</p><p>An accompanying tree-in–bud pattern is indicative of infectious bronchiolitis or aspiration. Rare causes of centrilobular nodules with tree-in-bud appearance are diffuse panbronchiolitis, follicular bronchiolitis, vascular tumor spread (tumor embolization), and so-called cellulose or talc granulomatosis in intravenous drug abusers.</p><p>Centrilobular ground-glass nodules can be seen in respiratory bronchiolitis of smokers, follicular bronchiolitis, and hypersensitivity pneumonitis (usually in non-smokers).</p><p>In rare instances, centrilobular nodules can be found in patients with plexogenic changes of pulmonary arterial hypertension, pulmonary veno-occlusive disease, and the related pulmonary capillary hemangiomatosis [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Airspace nodules</span><span class="headingEndMark"> — </span>Airspace nodules, previously also called "acinar" nodules, are centrilobular and can also form the "tree-in-bud" pattern, but they are slightly larger than typical centrilobular nodules. They are seen in bronchogenic (endobronchial) spread of tuberculosis, aspiration, infectious bronchiolitis, and diffuse panbronchiolitis. The pathologic correlate is an accumulation of pus, mucus, caseous material, or inflammatory infiltration of bronchiolar walls.</p><p class="headingAnchor" id="H6946204"><span class="h3">General approach</span><span class="headingEndMark"> — </span>An algorithmic approach to small nodules on HRCT can be attempted by asking, "Do the nodules touch the parietal pleura or the interlobar fissures?"</p><p class="bulletIndent1"><span class="glyph">●</span>If yes, then the nodules are likely to be perilymphatic or hematogenous. Clustering of the nodules suggests sarcoidosis, silicosis or lymphangitic carcinomatosis, the latter frequently with thickening of interlobular septa. Nonclustered, diffuse nodules that abut the pleural or the interlobar fissures are likely random, hematogenous nodules (eg, miliary tuberculosis, fungal dissemination, hematogenous metastatic disease, or septic embolization).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If no, then the presence or absence of a tree-in-bud pattern has to be determined: centrilobular nodules without tree-in-bud pattern are found in respiratory bronchiolitis, hypersensitivity pneumonitis, and LCH. Centrilobular nodules with tree-in-bud pattern are primarily found with infectious bronchiolitis and aspiration.</p><p></p><p class="headingAnchor" id="H11"><span class="h2">Increased attenuation</span><span class="headingEndMark"> — </span>Increased attenuation of lung parenchyma on HRCT is generally due to infectious or inflammatory processes.</p><p class="headingAnchor" id="H12"><span class="h3">Ground-glass opacification</span><span class="headingEndMark"> — </span>Ground-glass opacification refers to focal or diffuse veil-like opacification of the lung, which does not obscure the vascular structures or the rest of the anatomic details and does not yield air-bronchograms  (<a class="graphic graphic_diagnosticimage graphicRef81817" href="/d/graphic/81817.html" rel="external">image 6</a> and <a class="graphic graphic_diagnosticimage graphicRef57578" href="/d/graphic/57578.html" rel="external">image 7</a> and <a class="graphic graphic_diagnosticimage graphicRef106185" href="/d/graphic/106185.html" rel="external">image 8</a> and <a class="graphic graphic_diagnosticimage graphicRef122355" href="/d/graphic/122355.html" rel="external">image 9</a> and <a class="graphic graphic_diagnosticimage graphicRef116745" href="/d/graphic/116745.html" rel="external">image 10</a>). Ground-glass opacification was initially described on chest radiographs. The term was later adopted in CT reporting. It indicates sub-threshold parenchymal abnormalities below the spatial resolution of HRCT. It has an attenuation between minus 300 and minus 600 HU. Ground-glass opacification occurs in early interstitial lung disease  (<a class="graphic graphic_diagnosticimage graphicRef106188" href="/d/graphic/106188.html" rel="external">image 11</a>), with incomplete, early alveolar filling, with increased pulmonary capillary blood volume, and with partial collapse of alveoli, particularly on expiratory scans performed close to functional residual capacity of the lungs [<a href="#rid13">13-16</a>]. Claims that it solely represents early "alveolitis" have proven inaccurate. In approximately one-third of patients with interstitial lung disease, ground-glass opacity correlates with established fibrosis. In such cases, accompanying traction bronchiectases can usually be detected [<a href="#rid17">17</a>].</p><p>In rare instances, increased lung attenuation may be difficult to detect if it is diffuse, homogeneous, and subtle. A very conspicuous display of bronchi (ie, the "black bronchus" sign) is a helpful finding that suggests diffuse, subtle increased lung attenuation.</p><p>Subtle radiographic abnormalities may be accompanied by a marked decrease in the diffusion capacity for carbon monoxide (DLCO) of up to 50 percent, facilitating their recognition [<a href="#rid16">16</a>]. Examples of diseases that may present with subtle increased lung attenuation include early hypersensitivity pneumonitis, Pneumocystis jirovecii (formerly called Pneumocystis carinii) pneumonia, cellular nonspecific interstitial pneumonia, desquamative interstitial pneumonia, and subacute diffuse alveolar damage. In contrast, most diffuse lung diseases that present with ground-glass opacification are patchy, with multifocal variability in attenuation that is readily detected on an expiratory scan.</p><p>Multifocal, large, rounded, subpleural ground-glass opacities are characteristic for the early, exudative form of SARS-CoV-2-pneumonia (COVID-19 pneumonia) [<a href="#rid18">18,19</a>].</p><p>Acute diseases that manifest with diffuse ground-glass opacities include pulmonary edema, pulmonary hemorrhage  (<a class="graphic graphic_diagnosticimage graphicRef106187" href="/d/graphic/106187.html" rel="external">image 12</a>), Pneumocystis jirovecii pneumonia, mycoplasma and viral pneumonia, acute interstitial pneumonia (AIP), acute eosinophilic lung disease, and early hypersensitivity pneumonitis [<a href="#rid15">15</a>]. Among HIV-positive patients, ground-glass attenuation is present in 90 percent of patients with Pneumocystic jirovecii pneumonia and absent in 95 percent of patients who do not have Pneumocystic jirovecii pneumonia. Among immunocompromised patients without AIDS, ground-glass opacities may indicate Pneumocystic jirovecii pneumonia, drug reactions, pulmonary hemorrhage, or lymphoma.</p><p>Chronic pulmonary disorders that induce diffuse ground-glass opacification either as the only finding or in conjunction with fibrosis, interlobular and intralobular septal thickening, or nodules include hypersensitivity pneumonitis, desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), nonspecific interstitial pneumonia (NSIP), pulmonary alveolar proteinosis (PAP), bronchioloalveolar carcinoma also called adenocarcinoma-in-situ, organizing pneumonia, and sarcoidosis [<a href="#rid15">15</a>].</p><p>"Crazy paving" refers to ground-glass opacities with interspersed thickened interlobular and intralobular septa. Initially described in PAP, it can also be found in atypical pneumonia, including the early organizing phase of SARS-CoV-2 pneumonia, pulmonary hemorrhage, diffuse alveolar damage, and pseudoalveolar sarcoidosis [<a href="#rid20">20,21</a>]. (See  <a class="medical medical_review" href="/d/html/4356.html" rel="external">"Treatment and prognosis of pulmonary alveolar proteinosis in adults"</a> and  <a class="medical medical_review" href="/d/html/4373.html" rel="external">"Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults"</a>.)</p><p>Ground-glass opacities may be focal. Such opacities typically represent focal atelectasis, focal fibrosis, focal inflammation, atypical alveolar hyperplasia, or bronchioloalveolar carcinoma (ie, adenocarcinoma-in-situ) [<a href="#rid16">16</a>]. Follow-up scans after three months may show clearing if the focal ground-glass opacity is inflammatory in origin. However, if the focal ground-glass opacity persists and exceeds 10 mm in diameter, bronchioloalveolar carcinoma (adenocarcinoma-in-situ) should be suspected [<a href="#rid16">16</a>]. Smaller, circumscribed, persistent ground-glass opacities usually represent atypical alveolar hyperplasia. They grow in only 10 percent of cases and only 1 percent can yield a solid component and convert to a minimally invasive adenocarcinoma. This conversion takes at least 3.5 years [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Consolidation or airspace filling</span><span class="headingEndMark"> — </span>Consolidation or airspace filling causes opacification but, in contrast to ground-glass attenuation, it results in obscuration of vascular structures accompanied by air bronchograms  (<a class="graphic graphic_diagnosticimage graphicRef57246 graphicRef70172" href="/d/graphic/57246.html" rel="external">image 13A-B</a>). These changes are due to replacement of alveolar gas by pus, edema, blood, surfactant, or cells. In acute cases, pneumonia, pulmonary edema, diffuse alveolar damage [<a href="#rid23">23</a>], and pulmonary hemorrhage should be considered. In chronic cases, cryptogenic organizing pneumonia, chronic eosinophilic pneumonia, and bronchioloalveolar carcinoma (mucinous adenocarcinoma) are likely possibilities.</p><p>In rare cases, an interstitial process such as sarcoidosis can widen the alveolar septa and compress the alveoli but spare the bronchi, thus mimicking airspace filling disease (ie, pseudoalveolar sarcoidosis).</p><p class="headingAnchor" id="H14"><span class="h2">Decreased attenuation</span><span class="headingEndMark"> — </span>Decreased attenuation can result from emphysema, cystic lung disease, asthma, bronchiolitis obliterans with hypoxic vasoconstriction and gas-trapping, bronchial obstruction with gas-trapping due to a check valve obstruction, or pulmonary hypoperfusion from severe pulmonary hypertension, particularly if it is due to chronic thromboembolic disease (CTEPH). A generalized decrease in attenuation is unusual, but may be seen with increasing age due to an increase in the size of alveoli from 250 micrometers to 500 micrometers in diameter. It may also be seen in individuals with pulmonary arterial hypertension or a systemic sclerosis-related pulmonary vasculopathy, likely reflecting reduced compliance of the pulmonary arterial tree [<a href="#rid16">16</a>]. Emphysematous decrease in lung attenuation can measure minus 950 Hounsfield Units (HU) or lower on CT scans obtained during sustained inspiration whereas expiratory gas trapping due to small airways disease can register an attenuation of minus 856 HU [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Mosaic attenuation</span><span class="headingEndMark"> — </span>Redistribution of blood flow towards normal parts of the lung may lead to increased attenuation of uninvolved parenchyma. This pattern of variable regional attenuation of lung parenchyma due to regional differences in perfusion is known as mosaic perfusion or mosaic attenuation and leads to sharply defined heterogeneity of lung attenuation. In a majority of cases, it can result from regional variations in perfusion due to airway abnormalities with hypoxic vasoconstriction, less likely due to obstructive vascular disease [<a href="#rid25">25</a>], or areas of infiltrative lung disease with ground-glass attenuation interspersed between islands of normal lung [<a href="#rid26">26</a>]. It can be seen in up to 20 percent of abnormal HRCT studies performed for diffuse infiltrative lung disease.</p><p>Differentiation of increased attenuation due to focal increase in blood flow from true ground-glass attenuation can be made by evaluating the vessel size: vessel size and number will be equal in areas of increased and decreased attenuation when caused by infiltrative lung disease. Vessel size and number will be decreased in regions of hypoattenuation, when dealing with airways or vascular disease. Expiratory scans will amplify the areas of hypoxic vasoconstriction and gas-trapping in airways disease but will not affect regions of hypoperfusion resulting from vascular obstruction. In addition, bronchiolitis obliterans is frequently associated with bronchial wall thickening, bronchiectasis, bronchiolectasis, and lobular lucencies, whereas chronic thromboembolic disease and idiopathic pulmonary arterial hypertension are accompanied by dilation of the central pulmonary arteries and larger, better defined areas of hypoattenuation. Mosaic attenuation will accurately depict 95 percent of diffuse infiltrative diseases and 85 percent of small airways obstruction but only 40 percent of patients with chronic obstruction of pulmonary arterial branches.</p><p>Lobular gas-or air-trapping has been described in 40 to 60 percent of asymptomatic, nonsmoking individuals. It can be regarded as a normal variant, particularly on expiratory scans [<a href="#rid16">16</a>]. Lung affected by gas or air trapping usually shows a decrease in attenuation below minus 856 HU [<a href="#rid24">24,27</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Cystic lung disease</span><span class="headingEndMark"> — </span>Cysts are defined as focal regions of low attenuation with perceptible, well delineated walls, 2 mm or less in thickness. Emphysematous spaces and bullae usually have an imperceptible wall and occasionally central vessels. Bronchiectatic cysts display the signet ring or Cabochon ring sign due to an accompanying artery in their wall. Cysts can be seen in end-stage lung disease with honeycombing in IPF, collagen-vascular diseases with fibrosing alveolitis, Langerhans cell histiocytosis (LCH), lymphangioleiomyomatosis (LAM), lymphocytic interstitial pneumonia (LIP) with follicular bronchiolitis, and, rarely, in desquamative interstitial pneumonia (DIP).</p><p>The cysts in IPF characteristically are subpleural in location and multilayered, stacked or multi-tiered. In LCH, they are typically associated with nodules, have irregular, bizarre shapes, are diffusely or randomly distributed throughout the lung parenchyma, predominant in the upper and middle lung regions, and tend to spare the lung bases. In LAM, the cysts are round and are diffusely distributed throughout the entire lung. Tuberous sclerosis shows similar cysts but they can be accompanied by peripheral ground-glass or solid pulmonary nodules, three to eight mm in diameter due to micronodular pneumocyte hyperplasia (MNPH), resulting from proliferation of Type 2 pneumocytes. In immunocompromised patients, Pneumocystis jirovecii pneumonia can be associated with cysts that are upper lung predominant in up to 30 percent of cases. This is particularly common after aerosolized therapy or prophylaxis with <a class="drug drug_general" data-topicid="9752" href="/d/drug information/9752.html" rel="external">Pentamidine</a> which cannot reach the apices, rendering them more susceptible to Pneumocystis jirovecii pneumonia than the rest of the lungs.</p><p>Lung cysts are a characteristic finding in Birt-Hogg-Dubé syndrome which is the most common cause of familial spontaneous pneumothorax [<a href="#rid28">28-30</a>]. These basal, multiseptate, perivenous, "floppy," or paramediastinal cysts are associated with skin tags formed by fibrofolliculomas in hair follicles and renal tumors (eg, renal cell carcinoma). (See  <a class="medical medical_review" href="/d/html/2948.html" rel="external">"Hereditary kidney cancer syndromes", section on 'Birt-Hogg-Dubé syndrome'</a> and  <a class="medical medical_review" href="/d/html/6706.html" rel="external">"Pneumothorax in adults: Epidemiology and etiology"</a>.)</p><p>Pneumatoceles are associated with blunt or penetrating trauma, barotrauma in ventilated patients with ARDS, with Staphylococcal pneumonia, or after kerosene inhalation. Pneumatoceles have a tendency to enlarge with mechanical ventilation, but can regress with resolution of the underlying disease. Occasionally, cavitating metastatic nodules can resolve after chemotherapy or immunotherapy, eg, tumor necrosis factor inhibitors, leaving behind residual thin-walled cysts. Scattered, thin-walled cysts can be seen in up to 25 percent of healthy, nonsmoking older individuals in the absence of classic emphysema [<a href="#rid16">16,31</a>].</p><p class="headingAnchor" id="H17"><span class="h1">HRCT DISEASE DISTRIBUTION</span><span class="headingEndMark"> — </span>The zonal distribution of different lung diseases can be of help in arriving at a specific diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span>The upper (cranial) parts of the lung are typically involved in granulomatous diseases (eg, sarcoidosis and hypersensitivity pneumonitis), Langerhans cell histiocytosis, idiopathic pleuroparenchymal fibroelastosis and pneumoconioses, such as silicosis and coal workers' pneumoconiosis, but not asbestosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The lower (basal) parts of the lung tend to be affected in fibrosing lung diseases, such as idiopathic pulmonary fibrosis, collagen-vascular diseases, nonspecific interstitial pneumonia (NSIP), asbestosis, fibrosing drug reactions, and benign age-related or smoking-related [<a href="#rid32">32</a>] pulmonary fibrosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preferential involvement of the central, axial lung parenchyma occurs in sarcoidosis, lung parenchymal lymphoma, Kaposi's sarcoma, and with centrifugal extension of lymphangitic tumor from hilar lymph nodes into the lung periphery. Hydrostatic pulmonary edema can display a perihilar, so-called butterfly or batwing configuration. Acute pulmonary hemorrhage can also have a central, perihilar distribution with typical subpleural sparing. E-cigarette or vaping use-associated lung injury shows central and midlung involvement with sparing of the outer periphery of the lung [<a href="#rid33">33</a>]. Postengraftment pulmonary consolidation in patients with hematopoietic stem cell transplantation has a central distribution. Radiation pneumonitis has a central perihilar distribution after mediastinal tumor radiation therapy [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The periphery of the lung is more frequently affected in idiopathic pulmonary fibrosis, collagen-vascular diseases, asbestosis, drug reactions, eosinophilic lung disease, organizing pneumonia, desquamative interstitial pneumonia, rare cases of pseudoalveolar sarcoid, graft-versus-host disease, and unusual cases of mucinous adenocarcinoma (bronchioloalveolar cell carcinoma). In its early stages, COVID-19 pneumonia shows a predilection for the pulmonary periphery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The anterior (ventral) or posterior (dorsal) parts of the lungs can be involved in pulmonary edema. In most diseases, the anterior lung clears earlier than the dependent, basal lung due to the "bucket handle motion" of the anterior ribs during ventilation with larger excursions of the anterior lung. In diffuse alveolar damage, the dependent dorsal lung is initially consolidated and noncompliant, and the middle region of the lung shows primarily ground-glass changes that can revert with mechanical ventilation. The anterior or ventral aspects of the lung are least involved acutely and tend to be hyperventilated during mechanical ventilation. This ventral, disease-free lung has been called "baby lung" and is susceptible to barotrauma, volutrauma of mechanical ventilation and oxygen toxicity with subsequent delayed fibrosis of the anterior or ventral aspects of the lung in the recovery phase of diffuse alveolar damage [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A predisposition for involvement of the posterosuperior regions of the lung is found in reactivation mycobacterial or fungal infections, as well as silicosis. A predilection for involvement of the posteroinferior parts of the lung is observed in aspiration pneumonia, hydrostatic pulmonary edema, and asbestosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse involvement of the lung can be seen in lymphangioleiomyomatosis and in advanced stages of all of the above mentioned infiltrative lung diseases.</p><p></p><p class="headingAnchor" id="H18"><span class="h1">PULMONARY DISEASES</span><span class="headingEndMark"> — </span>Many diseases can be well characterized by HRCT, as discussed in this section.</p><p class="headingAnchor" id="H19"><span class="h2">Emphysema</span><span class="headingEndMark"> — </span>Emphysema formation follows a marked reduction in terminal and respiratory bronchioles with subsequent destruction of alveoli by neutrophils and macrophages. Four types of emphysema can be differentiated by HRCT with a high degree of sensitivity and specificity [<a href="#rid32">32,36,37</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Centrilobular emphysema occurs preferentially in the upper lobes and produces holes in the center of the secondary pulmonary lobules  (<a class="graphic graphic_diagnosticimage graphicRef82308" href="/d/graphic/82308.html" rel="external">image 14</a> and <a class="graphic graphic_diagnosticimage graphicRef122351" href="/d/graphic/122351.html" rel="external">image 15</a>), frequently with a visible vessel in the center of the lucency. The secondary pulmonary lobules are not destroyed. Centrilobular emphysema can become confluent and eventually lead to advanced destructive emphysema which can mimic panlobular emphysema [<a href="#rid38">38,39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Panlobular emphysema more commonly involves the lung bases, resulting in a generalized paucity of vascular structures; it also affects the entire secondary pulmonary lobule  (<a class="graphic graphic_diagnosticimage graphicRef57950" href="/d/graphic/57950.html" rel="external">image 16</a>). Classic panlobular emphysema is infrequent and is the result of alpha-1 antitrypsin deficiency [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paraseptal (distal acinar) emphysema produces small, subpleural, and sub-fissural collections of gas located in the periphery of the secondary pulmonary lobule  (<a class="graphic graphic_diagnosticimage graphicRef53689" href="/d/graphic/53689.html" rel="external">image 17</a>). It is considered a panlobular form of subpleural or subseptal destruction and represents a precursor of bullae  (<a class="graphic graphic_diagnosticimage graphicRef60307" href="/d/graphic/60307.html" rel="external">image 18</a> and <a class="graphic graphic_diagnosticimage graphicRef122352" href="/d/graphic/122352.html" rel="external">image 19</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paracicatricial or pericicatricial (irregular) emphysema is found in the vicinity of scars and is frequently accompanied by lung parenchymal distortion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Combined pulmonary fibrosis and emphysema consists of apical-predominant emphysema accompanied by basal pulmonary fibrosis with concurrent pulmonary arterial hypertension and a more dismal long-term prognosis. This combination of findings has been identified in 8 percent of patients with emphysema [<a href="#rid41">41,42</a>].</p><p></p><p>The attenuation coefficient of emphysematous lung usually decreases to a value below minus 950 HU [<a href="#rid27">27,41</a>].</p><p class="headingAnchor" id="H20"><span class="h3">Bullous disease</span><span class="headingEndMark"> — </span>HRCT is useful in the evaluation and treatment of patients with bullous disease  (<a class="graphic graphic_diagnosticimage graphicRef64765" href="/d/graphic/64765.html" rel="external">image 20</a>). The number, location, and extent of bullae, the state of the remaining lung, and the effect of the dominant bulla on other thoracic structures can be assessed. Large bullae do not compress adjacent structures since they display the property of increased compliance. Rather, the normal lung retracts away from the large bullae as a result of the normal, preserved elastic recoil of the lung parenchyma. Solitary giant bullae that produce marked relaxation atelectasis in the neighboring parenchyma and are not associated with generalized emphysema respond best to surgical therapy. Bullous disease is a manifestation of paraseptal emphysema in most cases [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H21"><span class="h2">Airways diseases</span><span class="headingEndMark"> — </span>HRCT is useful in assessing the caliber of the airways, as well as in detecting diseases of both large and small airways (eg, bronchiectasis and bronchiolitis) [<a href="#rid32">32,44</a>].</p><p class="headingAnchor" id="H6708425"><span class="h3">Airway caliber</span><span class="headingEndMark"> — </span>The caliber of a bronchus is assessed by comparing it to the diameter of the adjacent pulmonary artery branch. The normal arterial to bronchial ratio is close to 1 in the midlung, decreases to 0.8 to 0.9 in the upper lobes, and increases to about 1.2 in the lower lobes. At high altitude, these ratios are lower due to a reduced diameter of the pulmonary artery branches caused by hypoxic vasoconstriction. In older individuals, these ratios are similarly lower due to mild dilation of the bronchi [<a href="#rid16">16</a>]. Small airways are defined as bronchioles devoid of cartilage and with a luminal diameter of 2 mm or less. Bronchial wall thickening is a manifestation of chronic obstructive pulmonary disease (COPD) in smokers and of asthma in non-smokers; it is diagnostic when the thickness of a main, lobar or segmental bronchial wall exceeds 1.2 to 1.4 mm or the bronchial wall thickness exceeds 20 percent of the internal bronchial luminal diameter [<a href="#rid38">38,45</a>].</p><p class="headingAnchor" id="H22"><span class="h3">Bronchiectasis</span><span class="headingEndMark"> — </span>HRCT has replaced bronchography as the method of choice for diagnosing bronchiectasis  (<a class="graphic graphic_diagnosticimage graphicRef54378 graphicRef70276 graphicRef78762 graphicRef53471 graphicRef69987 graphicRef70396 graphicRef64077" href="/d/graphic/54378.html" rel="external">image 21A-G</a> and <a class="graphic graphic_diagnosticimage graphicRef122349" href="/d/graphic/122349.html" rel="external">image 22</a>); it has a sensitivity of 97 percent when using bronchography as the gold standard [<a href="#rid46">46</a>]. HRCT is also useful in the evaluation of hemoptysis, which is frequently due to subclinical bronchiectasis and endobronchial tumors; HRCT can detect the bleeding source in nearly 50 percent of cases [<a href="#rid47">47,48</a>]. (See  <a class="medical medical_review" href="/d/html/1444.html" rel="external">"Clinical manifestations and diagnosis of bronchiectasis in adults"</a>.)</p><p>Minimum intensity projection is another effective way of postprocessing axial thin section and evaluating bronchiectases. The etiology of bronchiectases can be deduced from the cranio-caudal or axial-to-periphery distribution of involved airways:</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiectases with upper or mid-lung predominance are found in patients with cystic fibrosis, sarcoidosis, tuberculosis, allergic bronchopulmonary aspergillosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiectases with anterior or ventral predominance are seen with atypical mycobacterial infection, as a sequela of acute respiratory distress syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiectases with lower lung predominance are expected in chronic aspiration, pulmonary fibrosis, primary ciliary dyskinesia, common variable immunodeficiency (CVID), and alpha-1 antitrypsin deficiency.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiectases with central predominance (in the fourth to sixth generation of bronchi) are found in tracheobronchomegaly Mounier-Kuhn syndrome, Williams-Campbell syndrome [<a href="#rid49">49</a>], and allergic bronchopulmonary aspergillosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Focal bronchiectases are visible with endobronchial or peribronchial tumors and in Swyer-James-McLeod syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse bronchiectases can be seen accompanying diffuse bronchiolitis obliterans [<a href="#rid50">50</a>]. Diffuse bronchiectases can be seen in CVID in tandem with granulomatous-lymphocytic interstitial lung disease, a necrotizing and lymphoproliferative disease process. It presents with widespread solid or ground-glass micronodules, smooth interlobular septal thickening with lower-lobe predominance, and accompanying enlarged hilar lymph nodes [<a href="#rid51">51</a>].</p><p></p><p>Bronchiectatic airways are easily seen as tubular structures that do not taper and can be seen within 1 cm of the pleura [<a href="#rid52">52</a>]. The dilated bronchi are usually 1.5 times wider in diameter than the accompanying pulmonary artery branch. This cross-sectional configuration resembles a signet ring and is therefore called the signet ring or Cabochon ring sign; it can help to differentiate a bronchiectatic cyst from other kinds of cysts. Larger cysts can mimic bullae, but their location in the central rather than the subpleural region and their segmental clustering are suggestive of bronchiectatic cysts  (<a class="graphic graphic_diagnosticimage graphicRef72706" href="/d/graphic/72706.html" rel="external">image 23</a> and <a class="graphic graphic_diagnosticimage graphicRef106195" href="/d/graphic/106195.html" rel="external">image 24</a> and <a class="graphic graphic_diagnosticimage graphicRef106196" href="/d/graphic/106196.html" rel="external">image 25</a> and <a class="graphic graphic_diagnosticimage graphicRef106190" href="/d/graphic/106190.html" rel="external">image 26</a>).</p><p>Airways remodeling also leads to thickening of the bronchial walls with luminal irregularities due to corrugation of cartilage and hypertrophy of mucus glands. Bronchial diverticulosis arises from focal depression, fusion, and dilation of bronchial gland ducts with herniation through muscle fibers. It can be seen in 12 percent of heavy smokers [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H23"><span class="h3">Bronchiolitis</span><span class="headingEndMark"> — </span>HRCT contributes to the diagnosis of small airways disease (bronchiolitis) [<a href="#rid25">25</a>] (see  <a class="medical medical_review" href="/d/html/4323.html" rel="external">"Overview of bronchiolar disorders in adults"</a>). Several types of bronchiolitis can be identified [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory bronchiolitis affects most smokers but is seen only in 20 percent of smokers on HRCT. It results from inertial impaction of particles at the bifurcation of small airways. It affects preferentially the upper lobes and yields centrilobular ground-glass nodules. It is frequently associated with respiratory bronchiolitis interstitial lung disease. (See  <a class="medical medical_review" href="/d/html/4319.html" rel="external">"Respiratory bronchiolitis-associated interstitial lung disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiolitis obliterans, also called constrictive bronchiolitis, is characterized by a pattern of mosaic attenuation with alternating oligemia and pseudo-ground glass. Normal parts of the lung are hyper-perfused and have increased attenuation, while abnormal lung regions are hypoperfused due to hypoxic vasoconstriction. Paired inspiratory and expiratory CT scans can define regions of lung involved with bronchiolitis by demonstrating unequal ventilation with gas trapping, leading to formation of a mosaic pattern. Some patients with constrictive bronchiolitis have mild associated bronchial dilation and bronchiectasis. Patients with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) may display findings similar to constrictive bronchiolitis, associated with centrilobular nodules [<a href="#rid55">55</a>]. Patients with severe refractory asthma may also show gas trapping on expiratory CT scans similar to bronchiolitis obliterans [<a href="#rid56">56,57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cellular bronchiolitis with nodules and branching lines, or "tree-in-bud" pattern. The pathologic basis for "tree-in-bud" pattern is an active bronchiolitis with inflammatory cells in the walls of distal airways together with inflammatory exudates and mucus impacting the lumen of bronchioles. The "tree-in-bud" pattern corresponds to dilated and impacted bronchioles imaged parallel or perpendicular to the imaging plane of CT. In rare instances, "tree-in-bud" pattern can be seen due to vascular abnormalities like tumor embolization or intravascular talc and <a class="drug drug_general" data-topicid="10153" href="/d/drug information/10153.html" rel="external">methylcellulose</a> particles deposited in pulmonary arterioles of intravenous drug abusers. Tree-in-bud opacities have been described in unusual cases of plexogenic pulmonary arterial hypertension and pulmonary capillary hemangiomatosis.</p><p></p><p class="bulletIndent1">Cellular bronchiolitis is a feature of infections, including bronchogenic/endobronchial spread of tuberculosis, respiratory syncytial virus, adenovirus, mycoplasma, and bronchiolo-invasive aspergillosis in immune compromised hosts. Aspiration, diffuse panbronchiolitis in Asian patients, asthma, postinflammatory bronchiectasis, and cystic fibrosis can also display this pattern. A similar pattern can be found in patients with hypersensitivity pneumonia leading to intense bronchiolar and peribronchiolar inflammation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Follicular bronchiolitis is defined as lymphoid hyperplasia of the bronchus-associated lymphoid tissue (BALT). It is characterized by the presence of hyperplastic germinal centers along the bronchioles. It may represent a variant of lymphocytic interstitial pneumonia (LIP). This type of bronchiolitis is seen in tandem with immunodeficiencies, collagen-vascular disease, and hypersensitivity reaction. The CT manifestations include centrilobular nodules, larger peribronchial nodules, and associated ground-glass opacities [<a href="#rid58">58</a>]. In conjunction with LIP, follicular bronchiolitis can lead to the formation of random cysts.</p><p></p><p class="headingAnchor" id="H24"><span class="h2">Lymphangitic carcinomatosis</span><span class="headingEndMark"> — </span>Pulmonary lymphangitic carcinomatosis is part of the spectrum of metastatic disease. Most cases result from dissemination of adenocarcinomas. Microhematogenous spread to the periphery of the lung, with subsequent retrograde, centripetal lymphatic extension toward the hilar region, is the responsible mechanism in approximately 75 percent of patients. The remaining cases are due to centrifugal extension from a hilar tumor or from an ipsilateral lung or breast carcinoma. In the latter settings, the lymphangitic spread is unilateral; in comparison, microhematogenous seeding is frequently bilateral.</p><p>HRCT can detect lymphangitic tumor in up to 50 percent of patients who are symptomatic but have normal appearing lungs on chest radiography. The imaging features of lymphangitic tumor are determined by the pattern of bronchovascular and lymphatic spread  (<a class="graphic graphic_diagnosticimage graphicRef69355 graphicRef79160" href="/d/graphic/69355.html" rel="external">image 27A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef116748" href="/d/graphic/116748.html" rel="external">image 28</a> and <a class="graphic graphic_diagnosticimage graphicRef122347" href="/d/graphic/122347.html" rel="external">image 29</a>) [<a href="#rid59">59</a>]. The characteristic findings are thickening of the interlobular septa, with beading caused by perilymphatic nodules, polygon or polygonal arcade formation, and thickening of the central bronchovascular structures (so-called central dots). In spite of the extensive involvement, the lung parenchyma is not distorted. The absent distortion distinguishes lymphangitic spread from sarcoidosis, which can otherwise produce similar findings but usually with less conspicuous thickening of interlobular septa.</p><p class="headingAnchor" id="H25"><span class="h2">Sarcoidosis</span><span class="headingEndMark"> — </span>Sarcoidosis affects both the lung parenchyma and lymphatic tissue with noncaseating granulomata. The classic presentation consists of enlargement of hilar and mediastinal lymph nodes with or without lung parenchymal involvement. In some patients, however, parenchymal disease occurs in the absence of obvious lymph node enlargement. Marked parenchymal distortion can occur in the late stages. HRCT can also detect pulmonary involvement in a subset of symptomatic patients who have a normal chest radiograph, thereby expediting or facilitating biopsy and diagnosis. Sarcoid-like granulomatosis with lymph node enlargement has been described as a complication of targeted cancer therapy with programmed death PD-1/PD-L1 inhibitors (checkpoint inhibitors) like <a class="drug drug_general" data-topicid="98764" href="/d/drug information/98764.html" rel="external">nivolumab</a> and <a class="drug drug_general" data-topicid="96957" href="/d/drug information/96957.html" rel="external">pembrolizumab</a> [<a href="#rid60">60-62</a>].</p><p>Characteristic features of sarcoidosis on HRCT include bilateral, symmetric hilar and mediastinal lymph node enlargement, thickening of bronchovascular bundles, bronchial wall thickening, bronchial narrowing, thickening and beading of interlobular septa, peribronchiolar and perilymphatic small unsharp nodules, ground-glass opacification; larger, parenchymal masses which consist of merged, confluent small nodules with individual separate nodules at the periphery of this conglomerate mass: this constellation of findings has been dubbed the galaxy sign [<a href="#rid63">63</a>]; consolidation (pseudoalveolar pattern), parenchymal bands, distortion of lung architecture, cysts, and traction bronchiectasis  (<a class="graphic graphic_diagnosticimage graphicRef56447 graphicRef79110 graphicRef80035" href="/d/graphic/56447.html" rel="external">image 30A-C</a> and <a class="graphic graphic_diagnosticimage graphicRef122356" href="/d/graphic/122356.html" rel="external">image 31</a> and <a class="graphic graphic_diagnosticimage graphicRef122364" href="/d/graphic/122364.html" rel="external">image 32</a> and <a class="graphic graphic_diagnosticimage graphicRef122360" href="/d/graphic/122360.html" rel="external">image 33</a>) [<a href="#rid64">64,65</a>] are other frequently described findings in patients with sarcoidosis. Preferential patchy subpleural, upper lobe, and peribronchovascular involvement is present. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a>.)</p><p>Amyloidosis can present with a nodular pattern or with an alveolar septal form. The nodular form of pulmonary amyloidosis manifests with solitary amyloidomas or multiple macronodules that mimic granulomatous disease with punctate or coarse calcifications or mimic malignant pulmonary metastatic disease. Alveolar septal amyloidosis is less common than the nodular form. It is characterized by well-defined micronodules, 2 to 4 mm in diameter in tandem with reticular opacities, interlobular septal thickening, confluent consolidations with a basal and peripheral predominance. The nodular form can be asymptomatic or only mildly symptomatic and has a good prognosis whereas the alveolar septal form is symptomatic and progressive, likely leading to pulmonary hypertension and respiratory failure [<a href="#rid66">66</a>].</p><p class="headingAnchor" id="H26"><span class="h2">Idiopathic interstitial pneumonias</span><span class="headingEndMark"> — </span>The idiopathic interstitial pneumonias (IIPs) are a subset of diffuse interstitial lung diseases of unknown cause, characterized by expansion of the interstitial compartment (ie, that portion of the lung parenchyma sandwiched between the epithelial and endothelial basement membranes) by an infiltrate of inflammatory cells. The inflammatory infiltrate is sometimes accompanied by fibrosis, either in the form of abnormal collagen deposition, collapse of alveoli, or proliferation of fibroblasts capable of collagen synthesis [<a href="#rid67">67</a>].</p><p>Seven types of idiopathic interstitial pneumonias have been described. They include usual interstitial pneumonia/idiopathic pulmonary fibrosis (UIP/IPF), nonspecific interstitial pneumonia (NSIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis interstitial lung disease (RBILD), acute interstitial pneumonia (AIP), cryptogenic organizing pneumonia (COP), and LIP. (See  <a class="medical medical_review" href="/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a>.)</p><p>Idiopathic pleuroparenchymal fibroelastosis (IPPFE) has been added to the group of idiopathic interstitial pneumonias.</p><p>Radiologic evaluation of the IIPs may obviate the need for tissue diagnosis (particularly in some cases of UIP/IPF). More often, it narrows the differential diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic pulmonary fibrosis</strong> – IPF (pathologically defined by the presence of UIP pattern) [<a href="#rid68">68</a>] is associated with characteristic radiographic changes [<a href="#rid69">69-73</a>]. The UIP pattern on HRCT is characterized by the presence of bibasal and peripheral, subpleural reticular opacities, often associated with traction bronchiectasis which is a marker for fibrosis. Membranes of collapsed alveoli as a result of scarring contribute to the linear and reticular opacities. Honeycombing is common and is critical for making a definitive diagnosis of IPF [<a href="#rid74">74</a>]. Honeycombing on HRCT is usually defined as subpleural, clustered, multilayered, stacked, or multi-tiered cystic air spaces with well-defined walls. The cystic spaces are typically 3 to 10 mm in diameter, but occasionally may be as large as 2.5 cm and may represent collapsed secondary pulmonary lobules around respiratory bronchioles  (<a class="graphic graphic_diagnosticimage graphicRef82237 graphicRef75204" href="/d/graphic/82237.html" rel="external">image 34A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef122362" href="/d/graphic/122362.html" rel="external">image 35</a> and <a class="graphic graphic_diagnosticimage graphicRef122363" href="/d/graphic/122363.html" rel="external">image 36</a>) [<a href="#rid75">75,76</a>]. Honeycombing may represent simplification of the lung architecture with collapsed secondary pulmonary lobules and bronchiolectasis. Temporal and spatial heterogeneity with concurrent injury and repair, are pathologic characteristics of IPF. Diffuse pulmonary ossifications manifesting as dendriform or nodular calcific opacities have been detected in up to 28 percent of patients with UIP/IPF and in 8 percent of patients with other IIPs. These ossifications were characterized by at least 10 small calcific opacities, particularly in regions of fibrotic lung disease with areas of reticulations [<a href="#rid77">77</a>]. They have to be differentiated from small calcified granulomata seen primarily in fungal diseases like histoplasmosis or remote mycobacterial disease. Diffuse or focal calcifications can also be seen with metastatic calcifications in patients with renal failure and a high calcium phosphate product or with dystrophic calcifications after healed diffuse alveolar damage.</p><p></p><p class="bulletIndent1">The presence of coexisting pleural abnormalities, micronodules, gas trapping, non-honeycomb cysts, extensive ground-glass opacities, consolidation, or a peribronchovascular-predominant distribution should lead to consideration of an alternative diagnosis [<a href="#rid75">75</a>]. End-stage hypersensitivity pneumonitis [<a href="#rid78">78</a>], nonspecific interstitial pneumonia, rheumatoid arthritis-interstitial lung disease (RA-ILD), Sjögren's disease [<a href="#rid79">79</a>], drug reactions and, rarely, sarcoidosis can also cause radiological findings similar to IPF [<a href="#rid80">80</a>]. Chronic cryptogenic organizing pneumonia can occasionally be mistaken for IPF; however, its radiologic features (peripheral abnormal regions of consolidation with air bronchograms or ground-glass opacities) and shorter time course are differentiating features [<a href="#rid81">81</a>].</p><p></p><p class="bulletIndent1">The most recent consensus conference classifies the HRCT findings into (1) a UIP pattern with, peripheral, subpleural, basal-predominant reticular opacities, traction bronchiectases, and honeycombing; typical UIP pattern correlates with UIP pathology in 90 percent of cases, (2) probable UIP pattern where the above mentioned findings are present except for honeycombing; corresponds with UIP pathology in 80 percent of cases, (3) indeterminate for UIP where the basal, peripheral predominance of opacities is absent and ground-glass or peribronchovascular opacities are present, and (4) alternate diagnosis. The indeterminate and alternative categories can still correlate with UIP pathology in 50 percent of cases.</p><p></p><p class="bulletIndent1">Fibrosis in connective tissue disease-associated interstitial lung disease can have the features of basal UIP with exuberant honeycomb cysts and a straight-edge sign, ie, horizontal demarcation of fibrosis from the upper lung, which can be normal or show anterior upper-lobe subpleural reticular changes and honeycombing [<a href="#rid82">82</a>].</p><p></p><p class="bulletIndent1">Variant patterns of interstitial pulmonary fibrosis are described in systemic lupus erythematosus, like island-like fibrosis with sharp margins, anterior upper-lobe sign, exuberant fibrosis, straight-edge sign, heterogeneous lung destruction with geographic areas of cicatricial emphysema, and architectural distortion with cystic changes distinct from classic subpleural honeycombing [<a href="#rid83">83,84</a>].</p><p></p><p class="bulletIndent1">In about 10 percent of patients with IPF, accelerated UIP occurs with sudden deterioration, diffuse alveolar damage, peripheral consolidation, and/or ground-glass opacification superimposed on the chronic UIP pattern with poor prognosis. These findings can be similar to de novo AIP, which is described below.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Combined pulmonary fibrosis and emphysema</strong> – The combination of emphysema in the upper lobes and fibrosis in the lower lobes is increasingly recognized as a distinct clinical phenotype in smokers, particularly in men in their sixth and seventh decade, and is compatible with two simultaneous conditions [<a href="#rid85">85</a>]. Honeycombing, reticular opacities, and traction bronchiectases are the most common findings in the lower lungs, while the upper lungs exhibit paraseptal and centrilobular emphysema [<a href="#rid86">86</a>]. The pattern of fibrosis reflects either IPF or NSIP. The emphysematous foci may have thicker walls than typically expected in bullae [<a href="#rid31">31</a>]. The total lung volume is preserved without the typical hyperexpansion of severe emphysema. Patients typically exhibit marked reduction in the diffusing capacity for carbon monoxide (DLCO) with otherwise near-normal pulmonary function tests [<a href="#rid3">3</a>]. Pulmonary arterial hypertension and lung cancer are more common in this cohort of patients [<a href="#rid85">85</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonspecific interstitial pneumonia</strong> – NSIP can occur in either a cellular or a fibrotic form. HRCT features include ground-glass attenuation in a diffuse or patchy distribution, preferentially along bronchovascular bundles, with reticular opacities and traction bronchiectasis [<a href="#rid87">87,88</a>]. Honeycombing is only rarely noted. NSIP also displays pathologically temporal and spatial homogeneity, which distinguishes this entity from UIP [<a href="#rid89">89</a>]. Relative sparing of the lung immediately adjacent to the pleura in the dorsal regions of the lower lobes is characteristic and can be seen in up to 30 percent of affected patients [<a href="#rid90">90</a>]. The radiographic appearance of NSIP is discussed in greater detail separately [<a href="#rid91">91</a>]. (See  <a class="medical medical_review" href="/d/html/112195.html" rel="external">"Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia", section on 'Chest imaging studies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory bronchiolitis interstitial pneumonia</strong> – RB-ILD is a smoking-related disease characterized by small peribronchiolar nodules and ground-glass opacification related to the accumulation of dusky pigmented macrophages in the bronchioles and adjacent alveoli. It represents the most common form of bronchiolitis and has an upper lobe predominance. Paired inspiratory and expiratory CT scans can define regions of lung involved with bronchiolitis by demonstrating unequal ventilation with gas trapping. (See  <a class="medical medical_review" href="/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Desquamative interstitial pneumonia</strong> – DIP is diagnosed almost exclusively in smokers. It is likely that DIP and RBILD are highly related if not identical lesions, differing only in the severity, location, and extent of the abnormality (ie, RBILD = mild/early DIP) [<a href="#rid92">92</a>]. RBILD has upper lobe predilection and is less likely at the bases, whereas desquamative interstitial pneumonia has a basal predominance. HRCT shows homogeneous ground-glass opacities without the peripheral reticular opacities and honeycombing that are typical of UIP. Rather, DIP is characterized by more confluent ground-glass and consolidative opacification of the basal lung periphery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute interstitial pneumonia</strong> – AIP (previously called Hamman–Rich syndrome) is clinically unique among the IIPs because of its rapid progression. It is also described as idiopathic acute respiratory distress syndrome (ARDS). HRCT shows bilateral symmetric areas of ground-glass opacification and consolidation with traction bronchiectasis [<a href="#rid93">93</a>]. These findings are due to diffuse alveolar damage (DAD) with increased permeability edema and hyaline membrane formation. (See  <a class="medical medical_review" href="/d/html/4369.html" rel="external">"Acute interstitial pneumonia (Hamman-Rich syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphocytic interstitial pneumonia</strong> – LIP is characterized by homogeneous infiltration of the interstitium with a monoclonal or polyclonal population of T lymphocytes and represents diffuse lymphoid hyperplasia of bronchial-associated lymphatic tissue. It can be seen in patients with Sjögren's disease but has become an AIDS-defining disease, particularly in children. It can progress to lymphoma of the lung parenchyma. On HRCT, pulmonary cysts, measuring up to 30 mm in diameter, occur in up to 70 percent of affected patients. The cysts are thin walled and predominantly located in the middle and lower lung zones with perivascular and subpleural distribution. These cysts are most likely associated with follicular bronchiolitis and are the result of gas-trapping and focal destruction of alveolar walls. Associated findings include bilateral ground-glass opacities, small centrilobular and subpleural nodules, thickening of the bronchovascular bundles, thickening of the interlobular septa, and mediastinal lymph node enlargement [<a href="#rid94">94</a>]. (See  <a class="medical medical_review" href="/d/html/4361.html" rel="external">"Lymphoid interstitial pneumonia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Organizing pneumonia</strong> – Organizing pneumonia, characterized pathologically by plugs of organizing fibroblastic tissue that originates in the alveolar ducts and extends into the bronchioles; it typically shows peribronchial and peripheral, subpleural areas of consolidation, ground-glass opacities, band-like opacities, interlobular septal thickening on HRCT, occasionally with traction bronchiectases and interspersed fibrotic, reticular changes with a perilobular pattern that forms poorly defined arcade-like or polygonal structures in subpleural location  (<a class="graphic graphic_diagnosticimage graphicRef81785" href="/d/graphic/81785.html" rel="external">image 37</a> and <a class="graphic graphic_diagnosticimage graphicRef116746" href="/d/graphic/116746.html" rel="external">image 38</a> and <a class="graphic graphic_diagnosticimage graphicRef106192" href="/d/graphic/106192.html" rel="external">image 39</a> and <a class="graphic graphic_diagnosticimage graphicRef116747" href="/d/graphic/116747.html" rel="external">image 40</a> and <a class="graphic graphic_diagnosticimage graphicRef106194" href="/d/graphic/106194.html" rel="external">image 41</a> and <a class="graphic graphic_diagnosticimage graphicRef122348" href="/d/graphic/122348.html" rel="external">image 42</a> and <a class="graphic graphic_diagnosticimage graphicRef122365" href="/d/graphic/122365.html" rel="external">image 43</a>) [<a href="#rid95">95</a>]. Another suggestive finding is the presence of rings or crescents of consolidation surrounding ground-glass opacities, which have been called the reversed halo sign and the atoll sign [<a href="#rid8">8,96</a>]. (See  <a class="medical medical_review" href="/d/html/4332.html" rel="external">"Cryptogenic organizing pneumonia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial pneumonia with autoimmune features (IPAF) – These patients have an NSIP pattern, an organizing pneumonia pattern, a combined NSIP and organizing pneumonia pattern, or a LIP pattern in tandem with clinical, morphologic and laboratory, serologic findings suspicious for an underlying autoimmune disease but without overt findings of a classic connective tissue disease. Additional radiologic findings include pleural effusions and pleural thickening, pericardial effusions and pericardial thickening, bronchiolitis and bronchiectasis, pulmonary arterial hypertension, pulmonary veno-occlusive disease and pulmonary hypertension related to hypoxic vasoconstriction [<a href="#rid97">97</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic pleuro-parenchymal fibroelastosis (IPPFE) – IPPFE results in apical-predominant fibrosis with extensive fibrosis of the visceral pleura and apical parenchymal loss of volume. It is observed in older men and occasionally after solid organ transplants. It can have a poor prognosis with a case-fatality rate of up to 50 percent in four months to two years.</p><p></p><p class="headingAnchor" id="H27"><span class="h2">Asbestosis</span><span class="headingEndMark"> — </span>Asbestosis leads to predominantly basal and dorsal lung parenchymal fibrosis  (<a class="graphic graphic_diagnosticimage graphicRef77568" href="/d/graphic/77568.html" rel="external">image 44</a>). Other characteristic findings include: peribronchiolar fibrosis that forms centrilobular nodules, intralobular and interlobular septal fibrosis that forms subpleural short lines, coarse parenchymal bands, and subpleural curvilinear bands that parallel the pleura and represent fibrotic bridging from one centrilobular region to the next [<a href="#rid98">98</a>]. Coarse honeycombing can be seen in advanced stages. Coexistent pleural plaques are frequently identified, particularly in patients with curvilinear subpleural lines. Some radiologists favor prone HRCT in patients with asbestosis to better display the fixed, nongravitational changes at the lung bases. (See  <a class="medical medical_review" href="/d/html/4307.html" rel="external">"Asbestos-related pleuropulmonary disease"</a>.)</p><p>In larger studies, up to 30 percent of asbestos-exposed individuals demonstrate an abnormal HRCT in spite of a normal chest radiograph. Asbestosis is associated with more parenchymal bands or long scars than UIP/IPF [<a href="#rid98">98</a>].</p><p class="headingAnchor" id="H28"><span class="h2">Langerhans cell histiocytosis</span><span class="headingEndMark"> — </span>Langerhans cell histiocytosis (LCH; eosinophilic granuloma, histiocytosis X) accounts for approximately 3 percent of all chronic infiltrative lung diseases. It presents in three forms:</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary involvement only in 60 percent of patients. This isolated pulmonary form (PLCH) is seen primarily in adult smokers, who account for 90 percent of such cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary and skeletal structures are affected in 20 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other systemic, visceral manifestations are seen in 20 percent.</p><p></p><p>On conventional radiographs, PLCH shows upper-lobe predominance, particularly in the initial stages. The first visible change includes small nodular opacities 2 to 5 mm in diameter with scattered rounded opacities or diffuse, miliary nodules. An intermediate reticular pattern becomes visible on chest radiograph in advanced disease.</p><p>HRCT has changed our understanding of the true imaging findings in this disorder [<a href="#rid99">99</a>]. Sharply defined or stellate centrilobular nodules are the initial finding on HRCT. In early stages, the nodules composed of Langerhans cells (antigen presenting cells) and eosinophils are centered on respiratory bronchioles and the adjacent interstitium. These nodules can cavitate and form a "cheerio pattern." Multiple thin-walled cysts of varying size and bizarre shape, are typically present diffusely throughout the upper and middle lung zones with relative sparing of the bases  (<a class="graphic graphic_diagnosticimage graphicRef58182 graphicRef69891" href="/d/graphic/58182.html" rel="external">image 45A-B</a>). Some of these cysts can resemble emphysematous bullae; the differentiating features are the slightly thicker wall and their diffuse location, permeating the entire cross-section of the lung parenchyma rather than the peripheral, subpleural region of the lung. The cysts have bizarre, irregular shapes, which can appear in combination with nodules, some of them cavitating, in the intermediate stages of the disease. Their etiology is not clear, but they seem to result from cavitation of nodules or represent dilated airways, imaged in cross-section. They result from inflammation that destroys bronchiolar walls and dilates airways. In addition pericicatricial emphysema can contribute to cyst formation [<a href="#rid100">100</a>].</p><p>Patients with PLCH preserve their lung volumes throughout the course of the disease. This contrasts with most other advanced interstitial lung diseases, in which shrinking lung volumes are the rule. (See  <a class="medical medical_review" href="/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis"</a>.)</p><p class="headingAnchor" id="H29"><span class="h2">Lymphangioleiomyomatosis</span><span class="headingEndMark"> — </span>Pulmonary lymphangioleiomyomatosis (LAM) affects women of reproductive age. It results from a hamartomatous proliferation and agglomeration of smooth muscle cells in the lung, likely related to excessive production of vascular endothelial growth factor. (See  <a class="medical medical_review" href="/d/html/4335.html" rel="external">"Sporadic lymphangioleiomyomatosis: Epidemiology and pathogenesis"</a>.)</p><p>The chest radiograph shows coarse reticular opacities, with or without pleural effusion and pneumothorax, as well as large lung volumes. HRCT demonstrates multiple cysts distributed diffusely throughout the lung  (<a class="graphic graphic_diagnosticimage graphicRef69954 graphicRef78552" href="/d/graphic/69954.html" rel="external">image 46A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef122357" href="/d/graphic/122357.html" rel="external">image 47</a> and <a class="graphic graphic_diagnosticimage graphicRef106189" href="/d/graphic/106189.html" rel="external">image 48</a>) [<a href="#rid101">101</a>]. The cysts in LAM are rounded and can be similar to those seen in LCH, though bizarre cyst shapes are unlikely in LAM. The distribution of cysts is different in these disorders. The cysts involve all compartments of the lung in LAM, but show an upper lobe predominance in LCH.</p><p class="headingAnchor" id="H30"><span class="h2">Pulmonary alveolar proteinosis</span><span class="headingEndMark"> — </span>Pulmonary alveolar proteinosis (PAP), also called pulmonary alveolar lipoproteinosis, is a rare disorder that is marked by alveolar filling with lipid-rich proteinaceous material accompanied by large, foamy macrophages and relatively few inflammatory cells. The median age at diagnosis is 39 years; most patients are male and around 70 percent have a history of smoking [<a href="#rid102">102</a>]. PAP has been described in severe combined immunodeficiency [<a href="#rid103">103</a>]. It is the result of disturbed clearance of surfactant from alveoli most likely due to lack of granulocyte-macrophage colony stimulating factor (GM-CSF). Auto-antibodies that target GM-CSF cause PAP in the majority of cases with subsequent dysfunction in alveolar macrophages and subsequent impaired catabolism and accumulation of surfactant lipids and proteins.</p><p>The predominant CT feature of PAP is ground-glass opacification with smoothly thickened interlobular septal and intralobular alveolar septal lines. This pattern is called "crazy paving" [<a href="#rid21">21</a>]. Lobular or geographic sparing are accompanying features. The differential diagnostic considerations include pulmonary edema, pneumonia, alveolar hemorrhage, and ARDS with diffuse alveolar damage [<a href="#rid104">104</a>]. (See  <a class="medical medical_review" href="/d/html/4373.html" rel="external">"Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults"</a>.)</p><p class="headingAnchor" id="H3816732513"><span class="h2">Severe acute respiratory syndrome coronavirus 2019 (SARS-COVID-19)</span><span class="headingEndMark"> — </span>The pandemic of COVID-19 began in December 2019 in Wuhan, China and spread around the globe. The virus affects multiple organ systems, but the most prevalent and life-threatening manifestation is the atypical pneumonia it induces.</p><p>Four stages in the evolution of CT findings were described:</p><p class="bulletIndent1"><span class="glyph">●</span>In the early stage (zero to four days after symptom onset) ground-glass opacities were found, though some patients had initially normal findings [<a href="#rid105">105</a>]. This acute, exudative stage of pneumonia presents in the first three to four days with multifocal, subpleural, and basal-predominant rounded and large ground-glass opacities  (<a class="graphic graphic_diagnosticimage graphicRef134885" href="/d/graphic/134885.html" rel="external">image 49</a> and <a class="graphic graphic_diagnosticimage graphicRef134888" href="/d/graphic/134888.html" rel="external">image 50</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In stage two, typically five to eight days after symptom onset, findings transition to an early organizing pneumonia with crazy paving pattern  (<a class="graphic graphic_diagnosticimage graphicRef134886" href="/d/graphic/134886.html" rel="external">image 51</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage three (the peak stage), which is typically 9 to 13 days after symptom onset, is characterized by multifocal or diffuse consolidation, which can evolve into acute fibrinous organizing pneumonia and diffuse alveolar damage  (<a class="graphic graphic_diagnosticimage graphicRef134887" href="/d/graphic/134887.html" rel="external">image 52</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After 14 days, in the late stage, a gradual resolution of consolidation and ground-glass opacification occurs while parenchymal bands, architectural distortion, and traction bronchiectases ensue [<a href="#rid105">105,106</a>]. More than 50 percent of hospitalized patients will show residual ground-glass opacities, parenchymal bands, perilobular thickening, reticular opacities, traction bronchiectases, or mosaic attenuation. These findings may persist for months and may only slowly resolve over 6 to 12 months [<a href="#rid107">107</a>].</p><p></p><p class="headingAnchor" id="H31"><span class="h2">Pneumocystis pneumonia</span><span class="headingEndMark"> — </span>Pneumocystis jirovecii pneumonia is one of the most common pulmonary infections in patients with AIDS. The chest radiograph is deceptively normal in about 10 percent of symptomatic patients, but subtle abnormalities can be seen on HRCT. The primary change is diffuse or patchy ground-glass opacification, occasionally forming a "crazy paving" pattern  (<a class="graphic graphic_diagnosticimage graphicRef74643 graphicRef55021" href="/d/graphic/74643.html" rel="external">image 53A-B</a>) [<a href="#rid21">21,108</a>]. Consolidative changes, nodules, and thickening of interlobular septa are rarely seen. Patients treated with aerosolized <a class="drug drug_general" data-topicid="9752" href="/d/drug information/9752.html" rel="external">pentamidine</a> may have preferential Pneumocystis involvement of the upper lobes and often display cystic changes, due to lack of pentamidine penetration in the pulmonary apices  (<a class="graphic graphic_diagnosticimage graphicRef56620" href="/d/graphic/56620.html" rel="external">image 54</a>). (See  <a class="medical medical_review" href="/d/html/3704.html" rel="external">"Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"</a>.)</p><p class="headingAnchor" id="H32"><span class="h2">Hypersensitivity pneumonitis</span><span class="headingEndMark"> — </span>Hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis) represents a type 3 allergic reaction or immune complex disease. The disease can be classified into cluster one and cluster two hypersensitivity pneumonia: Cluster one displays a mixture of diffuse or patchy ground-glass opacification with lobular sparing, lobular gas-trapping (so-called head-cheese pattern or three-attenuations pattern) similar to a mosaic pattern, and may resemble nonspecific interstitial pneumonia or may display centrilobular poorly defined airspace nodules in 50 percent of cases similar to respiratory bronchiolitis. The airways component is likely due to an allergic, cellular bronchiolitis incited by a variety of allergens and haptens [<a href="#rid54">54</a>].</p><p>Cluster two hypersensitivity pneumonitis is characterized by linear and reticular opacities with relative basal sparing  (<a class="graphic graphic_diagnosticimage graphicRef59749 graphicRef71870 graphicRef52041" href="/d/graphic/59749.html" rel="external">image 55A-C</a> and <a class="graphic graphic_diagnosticimage graphicRef106191" href="/d/graphic/106191.html" rel="external">image 56</a> and <a class="graphic graphic_diagnosticimage graphicRef122350" href="/d/graphic/122350.html" rel="external">image 57</a>) [<a href="#rid109">109,110</a>]. Untreated patients can eventually develop frank honeycombing and coarse fibrosis with scarring, traction bronchiectases, and loss of volume primarily in the upper lobes. Patients with fibrotic hypersensitivity pneumonitis can develop a UIP pattern [<a href="#rid54">54,78</a>]. (See  <a class="medical medical_review" href="/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H33"><span class="h1">HRCT OF INTERLOBULAR SEPTAL THICKENING</span><span class="headingEndMark"> — </span>Normally, only scattered interlobular septa are visible on HRCT, particularly in the upper lobes, since their thickness is at the limit of spatial resolution and only rarely exceeds 0.1 mm. Thickening of interlobular septa may result from accumulation of interstitial liquid, cells, or collagen and can be simulated by alveolar, paraseptal, perilobular pathological changes. Interlobular septal thickening can be smooth, nodular, or irregular in contour [<a href="#rid111">111</a>].</p><p>Smooth interlobular septal thickening is seen in hydrostatic interstitial pulmonary edema, allergic pulmonary edema, eg, transfusion-associated lung injury [<a href="#rid62">62</a>], central lymphatic obstruction due to bronchogenic carcinoma, fibrosing mediastinitis or pulmonary veno-occlusive disease (in conjunction with ground-glass opacities, mosaic attenuation pleural effusions, and dilated main pulmonary artery with normal-sized or small pulmonary veins), and lymphangitic carcinomatosis. Rarely, it can be seen in pulmonary alveolar proteinosis and when combined with ground-glass opacities, it yields the "crazy paving" pattern [<a href="#rid21">21</a>].</p><p>Nodular interlobular septal thickening can be observed in patients with lymphangitic carcinomatosis, sarcoidosis, silicosis, lymphoma, diffuse alveolar septal amyloidosis, and Kaposi's sarcoma. Occasionally, nodular thickening has been described in miliary tuberculosis and histoplasmosis, where random, perivascular nodules predominate.</p><p>Irregular interlobular thickening is seen in patients with usual interstitial pneumonia/idiopathic pulmonary fibrosis, collagen vascular diseases, and asbestosis.</p><p>Calcific interlobular septal thickening can be a rare feature of alveolar microlithiasis [<a href="#rid112">112</a>]. This disease actually only simulates interlobular septal thickening due to the high concentration of calcospherites in close apposition to the perilobular region of secondary pulmonary lobules rather than actual calcification of the interstitium [<a href="#rid113">113</a>].</p><p class="headingAnchor" id="H34"><span class="h1">HRCT IN FOCAL LUNG DISEASE</span><span class="headingEndMark"> — </span>HRCT can be helpful in focal lung diseases, such as granulomatosis with polyangiitis, conglomerate masses in sarcoidosis and pneumoconiosis with the so-called galaxy sign (a large mass or nodule formed by confluence of several nodules and surrounded by several smaller nodules), focal organizing pneumonia with the reversed halo sign and atoll sign [<a href="#rid114">114</a>], amiodarone-induced pneumonitis characterized by iodine deposition, rounded atelectasis, and cavitating malignancies  (<a class="graphic graphic_diagnosticimage graphicRef55999 graphicRef58121 graphicRef61100 graphicRef51436 graphicRef62407" href="/d/graphic/55999.html" rel="external">image 58A-E</a> and <a class="graphic graphic_diagnosticimage graphicRef122359" href="/d/graphic/122359.html" rel="external">image 59</a>) [<a href="#rid63">63</a>]. It can facilitate morphologic characterization of lesions, since bronchiectasis, air bronchograms, cavitation, clustered nodules, and spiculation of edges can be detected with a high degree of certainty.</p><p>The relationship of a nodule to fissures, as well as precise localization to a segment or lobe, can be achieved. If a bronchus feeds into a focal abnormality, the yield of bronchoscopic biopsy will be higher: HRCT can guide the procedure and predict its success rate  (<a class="graphic graphic_diagnosticimage graphicRef67317" href="/d/graphic/67317.html" rel="external">image 60</a> and <a class="graphic graphic_diagnosticimage graphicRef106186" href="/d/graphic/106186.html" rel="external">image 61</a>).</p><p class="headingAnchor" id="H7434128"><span class="h1">EFFECTS OF NORMAL AGING</span><span class="headingEndMark"> — </span>Progressive decrease in attenuation of the lungs is seen in healthy nonsmoking adults due to a progressive increase in alveolar diameter from 250 microns to 500 microns. A decrease of minus 50 HU has been registered between the ages of 20 and 70 years of age [<a href="#rid16">16</a>]. A physiologic increase in collagen with age may lead to subtle fibrosis with basal subpleural reticular opacities, identified in 60 percent of individuals beyond 75 years of age. This senile, age-related pulmonary fibrosis has been called by different designations, including presbyteric lung, geriatric interstitial lung disease, and mature interstitial lung disease (MATILD). It is related to a mild degree of interstitial fibrosis with traction bronchiectases and bronchiolectasis. Scattered thin-walled cysts in individuals older than 75 years of age with a random distribution have been described as well [<a href="#rid31">31</a>]. Gas or air trapping on expiratory scans becomes more common and can be seen in more than 60 percent of examined individuals. Mild senile bronchial dilation with a concurrent decrease in the arterial to bronchial ratio should not lead to the diagnosis of bronchiectases [<a href="#rid16">16</a>]. (See <a class="local">'Airway caliber'</a> above.)</p><p class="headingAnchor" id="H7434179"><span class="h1">EFFECTS OF SMOKING</span><span class="headingEndMark"> — </span>Smoking plays an important role in the development of<strong> </strong>several interstitial and small airways diseases including<strong> </strong>respiratory bronchiolitis, desquamative interstitial pneumonia, pulmonary Langerhans cell histiocytosis, and probably in idiopathic interstitial fibrosis, since about 70 percent of patients with interstitial pulmonary fibrosis (IPF) are current or former smokers. Rheumatoid arthritis associated interstitial lung disease (RA-ILD) occurs three times more frequently in smokers than in nonsmokers with rheumatoid arthritis. A centrilobular pattern is associated with respiratory bronchiolitis, which is characterized by accumulation of pigmented macrophages in the alveoli and alveolar ducts. These centrilobular nodules are precursors of smoker’s emphysema and can progress to centrilobular emphysema (ie, the nodules are replaced by centrilobular lucencies). Acute eosinophilic pneumonia in binge smokers and acute pulmonary hemorrhage with anti-glomerular basement membrane antibodies can be precipitated by smoking.</p><p>Asymptomatic smokers with normal lung function can display parenchymal nodules with low attenuation, ground-glass opacities, subpleural micronodules, subpleural reticular opacities, occasional honeycombing and traction bronchiectases, and nonemphysematous cysts. These findings occur in up to eight percent of the population of smokers [<a href="#rid41">41,85</a>]. The subpleural reticular opacities are similar to those seen in older individuals, but at an earlier age in smokers. Interstitial changes may mask the functional effect of concurrent emphysema with less overall hyperexpansion of the lungs. These interstitial findings in smokers may represent a mild form of nonspecific interstitial pneumonia, fibrosis subtype, and may indicate premature aging of the lungs [<a href="#rid16">16,85,115</a>]. Of note, smoking can be protective of hypersensitivity pneumonitis and sarcoidosis with an odds ratio for these diseases of 0.62. This protection may be the result of mild immunosuppression triggered by smoking.</p><p>Interstitial lung abnormalities (ILA) are detected as an incidental finding in more than 4 to 9 percent of smokers and 2 to 7 percent of nonsmokers on routine, non-contrast enhanced CT scans performed in older individuals without suspected interstitial lung disease. These findings have been identified in the COPDGene study and in the National Lung Cancer Screening Trial. ILAs have been defined as nondependent ground-glass opacities or diffuse centrilobular nodularity, reticular abnormalities, nonemphysematous cysts, honeycombing, and traction bronchiectasis. They are not regularly reported by radiologists when interpreting supine CT scans under the assumption that they are gravitational, dependent findings. Prone CT scans can determine the fixed nature of these abnormalities. ILAs are an emerging concept but are age-related or smoking-related and seen in patients with COPD. They can progress in more than 50 percent of identified individuals [<a href="#rid116">116</a>]. ILAs are associated with a decreased diffusion capacity for carbon monoxide and a decrease in total lung capacity likely associated with a greater risk of all-cause mortality, particularly due to respiratory diseases like pulmonary fibrosis and a higher likelihood of developing acute respiratory distress syndrome and diffuse alveolar damage [<a href="#rid116">116,117</a>].</p><p class="headingAnchor" id="H1092205240"><span class="h2">Electronic cigarette or vaping product use</span><span class="headingEndMark"> — </span>Electronic cigarettes can lead to complications. After vaping of tetrahydrocannabinol, nicotine, and possibly vitamin E acetate additives, patients can present with nondiagnostic respiratory (E-cigarette or vaping use associated lung injury [EVALI]), gastrointestinal, and constitutional symptoms.</p><p>Imaging patterns described in EVALI have a basal predominance, including consolidation and ground-glass opacification of the lung parenchyma with regions of subpleural and lobular sparing  (<a class="graphic graphic_diagnosticimage graphicRef134884" href="/d/graphic/134884.html" rel="external">image 62</a>).</p><p>Chest CT findings in EVALI most commonly show a pattern of organizing pneumonia.</p><p>Characteristic findings show consolidation and ground-glass opacification, sparing the peripheral and central subpleural regions, sparing of the peribronchovascular interstitium, and intermixed lobular sparing. Subtle interlobular septal thickening, centrilobular ground-glass nodules, and occasional bulla formation with subsequent spontaneous pneumothorax can be identified.</p><p>Overall, most pulmonary findings associated with vaping usually improve with therapy [<a href="#rid33">33</a>].</p><p>Diagnosis, pathology, and treatment of EVALI are discussed separately. (See  <a class="medical medical_review" href="/d/html/122671.html" rel="external">"E-cigarette or vaping product use-associated lung injury (EVALI)"</a> and  <a class="medical medical_review" href="/d/html/98400.html" rel="external">"Vaping and e-cigarettes"</a>.)</p><p class="headingAnchor" id="H35"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>High resolution CT (HRCT, also called thin-section CT scanning) provides more detail than either chest radiography or conventional CT scanning, with an overall sensitivity of 95 percent and a specificity approaching 100 percent. Compared with chest radiography, HRCT can more accurately assess the pattern and distribution of diffuse lung disease, which may be beneficial when trying to narrow the differential diagnosis or define a target for lung biopsy. (See <a class="local">'Clinical application of HRCT'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>HRCT patterns include linear and reticular opacities, nodular opacities, large confluent opacities (eg, ground-glass opacities, consolidation), and decreased parenchymal opacity (eg, emphysema, cystic lesions, mosaic attenuation, gas trapping). These patterns may be accompanied by parenchymal bands and architectural distortion. (See <a class="local">'HRCT patterns'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Distributions of disease include apical versus basal, central versus peripheral, anterior versus posterior, and diffuse. (See <a class="local">'HRCT disease distribution'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Major diseases that can be optimally characterized by HRCT include emphysema, bullous disease, airways diseases (eg, bronchiectasis, bronchiolitis), lymphangitic carcinomatosis, sarcoidosis, the idiopathic interstitial pneumonias, asbestosis, Langerhans cell histiocytosis, lymphangioleiomyomatosis, Pneumocystis pneumonia (PCP, now called Pneumocystis jirovecii pneumonia), hypersensitivity pneumonia, severe acute respiratory syndrome from COVID-19, and asymptomatic interstitial lung abnormalities. (See <a class="local">'Pulmonary diseases'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Epler GR, McLoud TC, Gaensler EA, et al. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298:934.</a></li><li><a class="nounderline abstract_t">Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171:111.</a></li><li><a class="nounderline abstract_t">Tseng HJ, Henry TS, Veeraraghavan S, et al. Pulmonary Function Tests for the Radiologist. Radiographics 2017; 37:1037.</a></li><li><a class="nounderline abstract_t">Müller NL, Miller RR. Computed tomography of chronic diffuse infiltrative lung disease. Part 1. Am Rev Respir Dis 1990; 142:1206.</a></li><li><a class="nounderline abstract_t">Müller NL, Miller RR. Computed tomography of chronic diffuse infiltrative lung disease. Part 2. Am Rev Respir Dis 1990; 142:1440.</a></li><li><a class="nounderline abstract_t">Müller NL. Clinical value of high-resolution CT in chronic diffuse lung disease. AJR Am J Roentgenol 1991; 157:1163.</a></li><li><a class="nounderline abstract_t">Bligh MP, Borgaonkar JN, Burrell SC, et al. Spectrum of CT Findings in Thoracic Extranodal Non-Hodgkin Lymphoma. Radiographics 2017; 37:439.</a></li><li><a class="nounderline abstract_t">Ujita M, Renzoni EA, Veeraraghavan S, et al. Organizing pneumonia: perilobular pattern at thin-section CT. Radiology 2004; 232:757.</a></li><li><a class="nounderline abstract_t">Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214:73.</a></li><li><a class="nounderline abstract_t">Webb WR. Thin-section CT of the secondary pulmonary lobule: anatomy and the image--the 2004 Fleischner lecture. Radiology 2006; 239:322.</a></li><li><a class="nounderline abstract_t">Fadl SA, Pillappa R, Parker MS. Minute Pulmonary Meningothelial-like Nodules. Radiol Cardiothorac Imaging 2021; 3:e210219.</a></li><li><a class="nounderline abstract_t">Delhaye C, Walsdorff M, Hackx M. Case 276: Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis Disease. Radiology 2020; 295:240.</a></li><li><a class="nounderline abstract_t">Remy-Jardin M, Remy J, Giraud F, et al. Computed tomography assessment of ground-glass opacity: semiology and significance. J Thorac Imaging 1993; 8:249.</a></li><li><a class="nounderline abstract_t">Collins J, Stern EJ. Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol 1997; 169:355.</a></li><li><a class="nounderline abstract_t">Miller WT Jr, Shah RM. Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations. AJR Am J Roentgenol 2005; 184:613.</a></li><li><a class="nounderline abstract_t">Hansell DM. Thin-section CT of the lungs: the Hinterland of normal. Radiology 2010; 256:695.</a></li><li><a class="nounderline abstract_t">Leung AN, Miller RR, Müller NL. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology 1993; 188:209.</a></li><li><a class="nounderline abstract_t">Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020; 295:202.</a></li><li><a class="nounderline abstract_t">Bernheim A, Mei X, Huang M, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020; 295:200463.</a></li><li><a class="nounderline abstract_t">Rossi SE, Erasmus JJ, Volpacchio M, et al. "Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics 2003; 23:1509.</a></li><li><a class="nounderline abstract_t">Lee CH. The crazy-paving sign. Radiology 2007; 243:905.</a></li><li><a class="nounderline abstract_t">Kakinuma R, Muramatsu Y, Kusumoto M, et al. Solitary Pure Ground-Glass Nodules 5 mm or Smaller: Frequency of Growth. Radiology 2015; 276:873.</a></li><li><a class="nounderline abstract_t">Gattinoni L, Caironi P, Pelosi P, Goodman LR. What has computed tomography taught us about the acute respiratory distress syndrome? Am J Respir Crit Care Med 2001; 164:1701.</a></li><li><a class="nounderline abstract_t">Occhipinti M, Paoletti M, Bigazzi F, et al. Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. Radiology 2018; 287:683.</a></li><li><a class="nounderline abstract_t">Eber CD, Stark P, Bertozzi P. Bronchiolitis obliterans on high-resolution CT: a pattern of mosaic oligemia. J Comput Assist Tomogr 1993; 17:853.</a></li><li><a class="nounderline abstract_t">Worthy SA, Müller NL, Hartman TE, et al. Mosaic attenuation pattern on thin-section CT scans of the lung: differentiation among infiltrative lung, airway, and vascular diseases as a cause. Radiology 1997; 205:465.</a></li><li><a class="nounderline abstract_t">Newell JD Jr. Quantitative computed tomography of lung parenchyma in chronic obstructive pulmonary disease: an overview. Proc Am Thorac Soc 2008; 5:915.</a></li><li><a class="nounderline abstract_t">Agarwal PP, Gross BH, Holloway BJ, et al. Thoracic CT findings in Birt-Hogg-Dube syndrome. AJR Am J Roentgenol 2011; 196:349.</a></li><li><a class="nounderline abstract_t">Dal Sasso AA, Belém LC, Zanetti G, et al. Birt-Hogg-Dubé syndrome. State-of-the-art review with emphasis on pulmonary involvement. Respir Med 2015; 109:289.</a></li><li><a class="nounderline abstract_t">Zamora CA, Rowe SP, Horton KM. Case 218: Birt-Hogg-Dubé syndrome. Radiology 2015; 275:923.</a></li><li><a class="nounderline abstract_t">Copley SJ, Wells AU, Hawtin KE, et al. Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old. Radiology 2009; 251:566.</a></li><li><a class="nounderline abstract_t">Lynch DA, Austin JH, Hogg JC, et al. CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. Radiology 2015; 277:192.</a></li><li><a class="nounderline abstract_t">Kligerman S, Raptis C, Larsen B, et al. Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): Evolving Knowledge and Remaining Questions. Radiology 2020; 294:491.</a></li><li><a class="nounderline abstract_t">Peña E, Souza CA, Escuissato DL, et al. Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosis. Radiographics 2014; 34:663.</a></li><li><a class="nounderline abstract_t">Gattinoni L, Chiumello D, Cressoni M, Valenza F. Pulmonary computed tomography and adult respiratory distress syndrome. Swiss Med Wkly 2005; 135:169.</a></li><li><a class="nounderline abstract_t">Bergin CJ, Müller NL, Miller RR. CT in the qualitative assessment of emphysema. J Thorac Imaging 1986; 1:94.</a></li><li><a class="nounderline abstract_t">Bonelli FS, Hartman TE, Swensen SJ, Sherrick A. Accuracy of high-resolution CT in diagnosing lung diseases. AJR Am J Roentgenol 1998; 170:1507.</a></li><li><a class="nounderline abstract_t">Lynch DA, Moore CM, Wilson C, et al. CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study. Radiology 2018; 288:859.</a></li><li><a class="nounderline abstract_t">El Kaddouri B, Strand MJ, Baraghoshi D, et al. Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study. Radiology 2021; 298:441.</a></li><li><a class="nounderline abstract_t">Strnad P, McElvaney NG, Lomas DA. Alpha1-Antitrypsin Deficiency. N Engl J Med 2020; 382:1443.</a></li><li><a class="nounderline abstract_t">Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364:897.</a></li><li><a class="nounderline abstract_t">Ufuk F. Combined Pulmonary Fibrosis and Emphysema. Radiology 2020; 296:275.</a></li><li><a class="nounderline abstract_t">Panchal, NJ, Stark, P. Bullous Lung disease. A review CDR. Contemporary Diagnostic Radiology 2006; 29:1.</a></li><li><a class="nounderline abstract_t">Hackx M, Bankier AA, Gevenois PA. Chronic obstructive pulmonary disease: CT quantification of airways disease. Radiology 2012; 265:34.</a></li><li><a class="nounderline abstract_t">Theriault MM, Eddy K, Borgaonkar JN, et al. Diseases Involving the Central Bronchi: Multidetector CT for Detection, Characterization, and Differential Diagnosis. Radiographics 2018; 38:58.</a></li><li><a class="nounderline abstract_t">Grenier P, Maurice F, Musset D, et al. Bronchiectasis: assessment by thin-section CT. Radiology 1986; 161:95.</a></li><li><a class="nounderline abstract_t">McGuinness G, Beacher JR, Harkin TJ, et al. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:1155.</a></li><li><a class="nounderline abstract_t">Naidich DP, Funt S, Ettenger NA, Arranda C. Hemoptysis: CT-bronchoscopic correlations in 58 cases. Radiology 1990; 177:357.</a></li><li><a class="nounderline abstract_t">Rohilla M, Previgliano C, Geimadi A, Sangster G. Williams-Campbell syndrome: an unusual presentation in an adult patient. BJR Case Rep 2021; 7:20200052.</a></li><li><a class="nounderline abstract_t">Milliron B, Henry TS, Veeraraghavan S, Little BP. Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases. Radiographics 2015; 35:1011.</a></li><li><a class="nounderline abstract_t">Torigian DA, LaRosa DF, Levinson AI, et al. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings. J Thorac Imaging 2008; 23:162.</a></li><li><a class="nounderline abstract_t">Kang EY, Miller RR, Müller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology 1995; 195:649.</a></li><li><a class="nounderline abstract_t">Worthy SA, Müller NL. Small airway diseases. Radiol Clin North Am 1998; 36:163.</a></li><li><a class="nounderline abstract_t">Winningham PJ, Martínez-Jiménez S, Rosado-de-Christenson ML, et al. Bronchiolitis: A Practical Approach for the General Radiologist. Radiographics 2017; 37:777.</a></li><li><a class="nounderline abstract_t">Schwartzstein RM, Medoff BD, Sharma A, et al. Case 4-2021: A 70-Year-Old Woman with Dyspnea on Exertion and Abnormal Findings on Chest Imaging. N Engl J Med 2021; 384:563.</a></li><li><a class="nounderline abstract_t">Jensen SP, Lynch DA, Brown KK, et al. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 2002; 57:1078.</a></li><li><a class="nounderline abstract_t">Barker AF, Bergeron A, Rom WN, Hertz MI. Obliterative bronchiolitis. N Engl J Med 2014; 370:1820.</a></li><li><a class="nounderline abstract_t">Howling SJ, Hansell DM, Wells AU, et al. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999; 212:637.</a></li><li><a class="nounderline abstract_t">Stein MG, Mayo J, Müller N, et al. Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 1987; 162:371.</a></li><li><a class="nounderline abstract_t">Nishino M, Hatabu H, Sholl LM, Ramaiya NH. Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care. Radiographics 2017; 37:1371.</a></li><li><a class="nounderline abstract_t">Nishino M, Hatabu H, Hodi FS. Imaging of Cancer Immunotherapy: Current Approaches and Future Directions. Radiology 2019; 290:9.</a></li><li><a class="nounderline abstract_t">Sridhar S, Kanne JP, Henry TS, et al. Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem. Radiographics 2022; 42:38.</a></li><li><a class="nounderline abstract_t">Aikins A, Kanne JP, Chung JH. Galaxy sign. J Thorac Imaging 2012; 27:W164.</a></li><li><a class="nounderline abstract_t">Müller NL, Kullnig P, Miller RR. The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 1989; 152:1179.</a></li><li><a class="nounderline abstract_t">Criado E, Sánchez M, Ramírez J, et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30:1567.</a></li><li><a class="nounderline abstract_t">Czeyda-Pommersheim F, Hwang M, Chen SS, et al. Amyloidosis: Modern Cross-sectional Imaging. Radiographics 2015; 35:1381.</a></li><li><a class="nounderline abstract_t">Wijsenbeek M, Cottin V. Spectrum of Fibrotic Lung Diseases. N Engl J Med 2020; 383:958.</a></li><li><a class="nounderline abstract_t">Lederer DJ, Martinez FJ. Idiopathic Pulmonary Fibrosis. N Engl J Med 2018; 378:1811.</a></li><li><a class="nounderline abstract_t">Staples CA, Müller NL, Vedal S, et al. Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings. Radiology 1987; 162:377.</a></li><li><a class="nounderline abstract_t">Müller NL, Staples CA, Miller RR, et al. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165:731.</a></li><li><a class="nounderline abstract_t">Wells A. Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis. Thorax 1998; 53:1080.</a></li><li><a class="nounderline abstract_t">Thomeer M, Demedts M, Behr J, et al. Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J 2008; 31:585.</a></li><li><a class="nounderline abstract_t">Assayag D, Elicker BM, Urbania TH, et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 2014; 270:583.</a></li><li><a class="nounderline abstract_t">Watadani T, Sakai F, Johkoh T, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 2013; 266:936.</a></li><li><a class="nounderline abstract_t">Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788.</a></li><li><a class="nounderline abstract_t">Mai C, Verleden SE, McDonough JE, et al. Thin-Section CT Features of Idiopathic Pulmonary Fibrosis Correlated with Micro-CT and Histologic Analysis. Radiology 2017; 283:252.</a></li><li><a class="nounderline abstract_t">Egashira R, Jacob J, Kokosi MA, et al. Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations. Radiology 2017; 284:255.</a></li><li><a class="nounderline abstract_t">Sahin H, Brown KK, Curran-Everett D, et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244:591.</a></li><li><a class="nounderline abstract_t">Egashira R, Kondo T, Hirai T, et al. CT findings of thoracic manifestations of primary Sjögren syndrome: radiologic-pathologic correlation. Radiographics 2013; 33:1933.</a></li><li><a class="nounderline abstract_t">Sverzellati N, Wells AU, Tomassetti S, et al. Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254:957.</a></li><li><a class="nounderline abstract_t">Müller NL, Guerry-Force ML, Staples CA, et al. Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical, functional, and radiologic findings. Radiology 1987; 162:151.</a></li><li><a class="nounderline abstract_t">Chung JH, Cox CW, Montner SM, et al. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol 2018; 210:307.</a></li><li><a class="nounderline abstract_t">Brady D, Berkowitz EA, Sharma A, et al. CT Morphologic Characteristics and Variant Patterns of Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus. Radiol Cardiothorac Imaging 2021; 3:e200625.</a></li><li><a class="nounderline abstract_t">White CS. Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus: Are There Variants of the Variant Fibrotic Patterns? Radiol Cardiothorac Imaging 2021; 3:e210183.</a></li><li><a class="nounderline abstract_t">King TE Jr. Smoking and subclinical interstitial lung disease. N Engl J Med 2011; 364:968.</a></li><li><a class="nounderline abstract_t">Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144:234.</a></li><li><a class="nounderline abstract_t">Lynch DA. Nonspecific interstitial pneumonia: evolving concepts. Radiology 2001; 221:583.</a></li><li><a class="nounderline abstract_t">Kligerman SJ, Groshong S, Brown KK, Lynch DA. Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations. Radiographics 2009; 29:73.</a></li><li><a class="nounderline abstract_t">MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221:600.</a></li><li><a class="nounderline abstract_t">Silva CI, Müller NL, Hansell DM, et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247:251.</a></li><li><a class="nounderline abstract_t">Sumikawa H, Johkoh T, Fujimoto K, et al. Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern. Radiology 2014; 272:549.</a></li><li><a class="nounderline abstract_t">Heyneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 1999; 173:1617.</a></li><li><a class="nounderline abstract_t">Johkoh T, Müller NL, Taniguchi H, et al. Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211:859.</a></li><li><a class="nounderline abstract_t">Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse Cystic Lung Disease. Part II. Am J Respir Crit Care Med 2015; 192:17.</a></li><li><a class="nounderline abstract_t">Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics 2013; 33:1951.</a></li><li><a class="nounderline abstract_t">Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol 2003; 180:1251.</a></li><li><a class="nounderline abstract_t">Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46:976.</a></li><li><a class="nounderline abstract_t">Gamsu G, Salmon CJ, Warnock ML, Blanc PD. CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. AJR Am J Roentgenol 1995; 164:63.</a></li><li><a class="nounderline abstract_t">Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172:255.</a></li><li><a class="nounderline abstract_t">Ahuja J, Kanne JP, Meyer CA, et al. Histiocytic disorders of the chest: imaging findings. Radiographics 2015; 35:357.</a></li><li><a class="nounderline abstract_t">Müller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175:335.</a></li><li><a class="nounderline abstract_t">D'Silva K, Brown S, Hunninghake GM, et al. Gasping for a Diagnosis. N Engl J Med 2019; 380:961.</a></li><li><a class="nounderline abstract_t">Rodriguez JA, Bang TJ, Restrepo CS, et al. Imaging Features of Primary Immunodeficiency Disorders. Radiol Cardiothorac Imaging 2021; 3:e200418.</a></li><li><a class="nounderline abstract_t">Frazier AA, Franks TJ, Cooke EO, et al. From the archives of the AFIP: pulmonary alveolar proteinosis. Radiographics 2008; 28:883.</a></li><li><a class="nounderline abstract_t">Pan F, Ye T, Sun P, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology 2020; 295:715.</a></li><li><a class="nounderline abstract_t">Kwee TC, Kwee RM. Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics 2020; 40:1848.</a></li><li><a class="nounderline abstract_t">Solomon JJ, Heyman B, Ko JP, et al. CT of Post-Acute Lung Complications of COVID-19. Radiology 2021; 301:E383.</a></li><li><a class="nounderline abstract_t">Bergin CJ, Wirth RL, Berry GJ, Castellino RA. Pneumocystis carinii pneumonia: CT and HRCT observations. J Comput Assist Tomogr 1990; 14:756.</a></li><li><a class="nounderline abstract_t">Silver SF, Müller NL, Miller RR, Lefcoe MS. Hypersensitivity pneumonitis: evaluation with CT. Radiology 1989; 173:441.</a></li><li><a class="nounderline abstract_t">Yoshizawa Y, Ohtani Y, Hayakawa H, et al. Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey. J Allergy Clin Immunol 1999; 103:315.</a></li><li><a class="nounderline abstract_t">Kang EY, Grenier P, Laurent F, Müller NL. Interlobular septal thickening: patterns at high-resolution computed tomography. J Thorac Imaging 1996; 11:260.</a></li><li><a class="nounderline abstract_t">Ferreira Francisco FA, Pereira e Silva JL, Hochhegger B, et al. Pulmonary alveolar microlithiasis. State-of-the-art review. Respir Med 2013; 107:1.</a></li><li><a class="nounderline abstract_t">Delic JA, Fuhrman CR, Trejo Bittar HE. Pulmonary Alveolar Microlithiasis: AIRP Best Cases in Radiologic-Pathologic Correlation. Radiographics 2016; 36:1334.</a></li><li><a class="nounderline abstract_t">Hsu A, Stark P, Friedman P. Focal organizing pneumonia with reversed halo sign. Applied Radiology 2007; 36:45.</a></li><li><a class="nounderline abstract_t">Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013; 268:563.</a></li><li><a class="nounderline abstract_t">Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial Lung Abnormalities: State of the Art. Radiology 2021; 301:19.</a></li><li><a class="nounderline abstract_t">Hatabu H, Hunninghake GM, Lynch DA. Interstitial Lung Abnormality: Recognition and Perspectives. Radiology 2019; 291:1.</a></li></ol></div><div id="topicVersionRevision">Topic 6988 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/642974" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Normal chest roentgenograms in chronic diffuse infiltrative lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2928513" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28598732" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pulmonary Function Tests for the Radiologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2240845" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Computed tomography of chronic diffuse infiltrative lung disease. Part 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2252265" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Computed tomography of chronic diffuse infiltrative lung disease. Part 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1950859" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical value of high-resolution CT in chronic diffuse lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28287948" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Spectrum of CT Findings in Thoracic Extranodal Non-Hodgkin Lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15229349" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Organizing pneumonia: perilobular pattern at thin-section CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10644104" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Lung nodule enhancement at CT: multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16543587" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Thin-section CT of the secondary pulmonary lobule: anatomy and the image--the 2004 Fleischner lecture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34778789" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Minute Pulmonary Meningothelial-like Nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32176598" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Case 276: Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8246323" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Computed tomography assessment of ground-glass opacity: semiology and significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9242736" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Ground-glass opacity at CT: the ABCs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15671387" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20720066" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Thin-section CT of the lungs: the Hinterland of normal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8511299" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32017661" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32077789" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14615561" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : "Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17517945" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The crazy-paving sign.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25906182" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Solitary Pure Ground-Glass Nodules 5 mm or Smaller: Frequency of Growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719313" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : What has computed tomography taught us about the acute respiratory distress syndrome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29361243" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8227568" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Bronchiolitis obliterans on high-resolution CT: a pattern of mosaic oligemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9356630" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Mosaic attenuation pattern on thin-section CT scans of the lung: differentiation among infiltrative lung, airway, and vascular diseases as a cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19056716" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Quantitative computed tomography of lung parenchyma in chronic obstructive pulmonary disease: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21257886" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Thoracic CT findings in Birt-Hogg-Dube syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25519092" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Birt-Hogg-Dubésyndrome. State-of-the-art review with emphasis on pulmonary involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25997135" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Case 218: Birt-Hogg-Dubésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19401580" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25961632" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31990264" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): Evolving Knowledge and Remaining Questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24819788" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15846529" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pulmonary computed tomography and adult respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3599139" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : CT in the qualitative assessment of emphysema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9609163" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Accuracy of high-resolution CT in diagnosing lung diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29762095" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33320065" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32268028" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Alpha1-Antitrypsin Deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21388308" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Lung volumes and emphysema in smokers with interstitial lung abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32368964" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Combined Pulmonary Fibrosis and Emphysema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A review CDR</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22993219" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Chronic obstructive pulmonary disease: CT quantification of airways disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29320325" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Diseases Involving the Central Bronchi: Multidetector CT for Detection, Characterization, and Differential Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3763889" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Bronchiectasis: assessment by thin-section CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8162743" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hemoptysis: prospective high-resolution CT/bronchoscopic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2217769" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Hemoptysis: CT-bronchoscopic correlations in 58 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33614112" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Williams-Campbell syndrome: an unusual presentation in an adult patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26024063" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18728542" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7753989" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9465873" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Small airway diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28362556" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Bronchiolitis: A Practical Approach for the General Radiologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33567196" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Case 4-2021: A 70-Year-Old Woman with Dyspnea on Exertion and Abnormal Findings on Chest Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12475532" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : High-resolution CT features of severe asthma and bronchiolitis obliterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24806161" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Obliterative bronchiolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10478225" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Follicular bronchiolitis: thin-section CT and histologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3797649" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pulmonary lymphangitic spread of carcinoma: appearance on CT scans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28898185" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30457485" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34826256" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23059737" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Galaxy sign.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2718853" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The CT findings of pulmonary sarcoidosis: analysis of 25 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21071376" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26230754" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Amyloidosis: Modern Cross-sectional Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32877584" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Spectrum of Fibrotic Lung Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742380" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Idiopathic Pulmonary Fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3797650" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3685351" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10195083" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18057059" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24126367" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23220902" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Interobserver variability in the CT assessment of honeycombing in the lungs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21471066" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27715655" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Thin-Section CT Features of Idiopathic Pulmonary Fibrosis Correlated with Micro-CT and Histologic Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28182861" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17641377" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24224588" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : CT findings of thoracic manifestations of primary Sjögren syndrome: radiologic-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20177106" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3786754" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical, functional, and radiologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29140119" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34498003" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : CT Morphologic Characteristics and Variant Patterns of Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34498011" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus: Are There Variants of the Variant Fibrotic Patterns?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21388315" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Smoking and subclinical interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23370641" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719646" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Nonspecific interstitial pneumonia: evolving concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19168837" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719652" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18270375" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24661246" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10584810" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10352616" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Acute interstitial pneumonia: thin-section CT findings in 36 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25906201" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Diffuse Cystic Lung Disease. Part II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24224590" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12704033" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26160873" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7998570" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2787036" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Pulmonary histiocytosis X: evaluation with high-resolution CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25763722" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Histiocytic disorders of the chest: imaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2326457" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30855747" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Gasping for a Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33969305" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Imaging Features of Primary Immunodeficiency Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18480490" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : From the archives of the AFIP: pulmonary alveolar proteinosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32053470" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33095680" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Chest CT in COVID-19: What the Radiologist Needs to Know.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34374591" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : CT of Post-Acute Lung Complications of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2398155" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Pneumocystis carinii pneumonia: CT and HRCT observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2798875" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Hypersensitivity pneumonitis: evaluation with CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9949324" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8892195" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Interlobular septal thickening: patterns at high-resolution computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23183116" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Pulmonary alveolar microlithiasis. State-of-the-art review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27618319" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Pulmonary Alveolar Microlithiasis: AIRP Best Cases in Radiologic-Pathologic Correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Focal organizing pneumonia with reversed halo sign</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23513242" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34374589" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Interstitial Lung Abnormalities: State of the Art.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30561274" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Interstitial Lung Abnormality: Recognition and Perspectives.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
